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Introduction
The indiscriminate prescription of antibiotics by physicians, along with their incor-
rect use [1] 1 has increased the exposition of bacteria to antibiotics, and thus has
created a favorable environment for the Darwinian evolution of resistant strains
[2]. Further increase of drug resistance is caused by the unnecessary massive use
of antibiotics (70% of the total market is in the US!) to animals crammed into the
unhygienic crowded quarters of factories [3, 4].
Diseases like tubercolosis, gonorrhea, malaria, and childhood ear infections,
are increasingly becoming hard to treat with antibiotic drugs, posing serious con-
cern in the human public health [5, 6].
The problem is even more serious if one considers that already in 70’s and 80’s
that modification of the chemical structure of the already known antibiotics turned
out to be exhausted and, at the same time, pharmacological companies decided not
design of totally new antibiotics [2].
As a result, the number of clinically useful antibiotics today remains almost the
same of twenty years ago [2] and scientists in universities and in public research
institutions are practically the only ones investigating bacterial drug resistance.
The most serious issues are connected to β -lactams antibiotics (Fig. 1.9 1.10
1.11), which are the most used class of drugs against pathologies connected to
bacteria [7]. Since they are indicated for the prophylaxis and treatment of bacterial
infections, they are used also for all surgeon interventions [8].
One of the primary β -lactam resistance strategy is the bacterial biosynthesis
of the β -lactamases enzymes [9], which catalyze the hydrolytic cleavage of the
β -lactam ring (Fig. 1).
Table 1: General and schematic hydrolysis reaction of β -lactam ring catalyzed by
β -lactamases.
1i.e. sporadic use of these drugs and/or incomplete treatment of bacterial infections.
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These enzymes are divided into four classes: A, B, C and D. in which, ac-
cording to the type of active site, one could identify two groups. Enzymes which
belong to class A, C and D perform the hydrolytic reaction using a serine residue,
while class B are Zn-dependent enzymes (called metallo-β -lactamases, MβLs).
Although MβLs constitute only the 10% of the overall lactamase family [10], they
represent a major concern in the clinical settings [11]. In fact: i) they feature a
broad spectrum profile, which encompasses most β -lactam antibiotics; ii) there is
the possibility of horizontal transfer (for details see section 1.1.1) among bacteria
species of genes which encode the resistance to chemotherapy [12]; iii) clinically
useful inhibitors are lacking.
MβLs exist in different subclasses (B1, B2 and B3), which differ in Zn con-
tent (one or two Zn ions) and substrate diversity [10]. B1 and B3 members are
catalytically active in vitro in both the mono- and di-zinc forms, with different co-
ordination polyhedra (Fig. 1). B2 members, on the other way, are mononuclear
Figure 1: ’Zn1’ and ’Zn2’ binding sites in MβLs, as observed in the B1 BCII
enzyme from Bacillus cereus [13] (residues are cut at the Cα , the B2 CphA enzyme
from Aeromonas hydrophila [14] and the B3 L1 enzyme from Stenotrophomonas
maltophilia [15]. In the case of the B1 enzyme, a second solvent molecule binds
to the metal ion. The backbone units of the residues are not shown for clarity.
enzymes only (Fig. 1), and they show a selective carbapenemase activity. 2
A large effort is being therefore made to develop MβLs inhibitors. Two major
problems are associated with such drug development. The first is that eventual
MβLs inhibitors which manage to block one of those may not be able to inhibit
the other subclasses, with consequent little beneficial effect. Second, bacteria may
express MβLs variants to counteract drug action, as already happened for serine-
β -lactamases [19].
In this thesis, I have used molecular simulations approaches, to enlarge our
understanding of MβLs structure and function. This in turn might help to address
these very serious issues.
2Carbapenem are latest generation of β -lactam antibiotics, which have shown the broadest spec-
trum of activity within this antibiotic class. They exhibit in vitro bactericidal activity against numer-
ous pathogens, including Gram-positive and Gram-negative aerobes and anaerobes (Fig. 1.11). In
addition carbapenems are stable to almost all β -lactamases [16, 17, 18].
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Concerning the first issue, I have formulated the following working hypothesis:
it is possible that MβLs, in spite their differences in active site residues, metal
content and activity, share common aspects in the catalytic reaction? If that would
be the case, one might try to design transition state analogues of the enzymatic
reaction, which may inhibit some or all MβLs subclasses, with increased beneficial
effects.
This hypothesis has been prompted by a large body of work in our Sector few
years ago. This work showed that a very large class of enzymes, the proteases,
share striking functional similarities in spite of the different fold and active site
architecture [20, 21].
At the time I had started this thesis, mechanistic studies had been carried out
only for B1 subclass, by us [22, 23], and other research groups [24, 25, 26, 27, 28].
To make comparison across different subclasses, here I then focused on the
CphA from Aeromonas hydrophila, the first enzyme belonging to B2 subclass
whose X-ray structure was solved in complex with a partially hydrolyzed sub-
strate [14]. I have used exactly the same computational setup, which consists of
DFT calculations, classical MD calculations and hybrid Car-Parrinello QM/MM
calculations, as that used for B1 [22, 23]: this was done to make our comparison
meaningful.
Anticipating our results, we find the B1 and B2 subclasses share strikingly
similar mechanisms of action, suggesting that the architecture and Zn content may
vary across the enzymes, but mechanistic features may be conserved. This could be
of help to design transition-state analogue inhibitors which block two of the three
subclasses. The work has been done in collaboration with one of the crystallogra-
phers (Dr. G. Garau) and with Prof. A. Vila, Rosario, Argentina, one of the leading
scientists investigating MβLs.
Several discussions with Vila’s lab also prompted us to address a second issue.
In a very important contribution [29], Vila’s lab has challenged the B1 MβL, BcII
from Bacillus cereus, to a direct evolution scheme, this has allowed to identify
mutations, which may cause drug resistance, and yet they have not been isolated in
the clinics.
The isolated BcII protein of the evolved Bacillus cereus bacteria was character-
ized by five point mutations. We investigated the structural and functional role of
some of these mutations. Using classical MD simulations of the evolved BcII vari-
ants, we were able to provide a rational (at qualitative level) for the experimentally
observed change in the catalytic rate.
A first mutation (G262S), close to the cleavage site, affects the reaction be-
cause it tunes the metal charge, leading to stabilization of a catalytically relevant
intermediate. The second mutation (N70S-G262S), located far from the active site,
causes an increase of the shape and flexibility of the active site cavity, which in
turn may have an impact on the enzyme reactivity.
These findings could be exploited to propose a strategy for designing a mechanism-
based inhibitor with an evolutionary perspective, namely anionic transition state
analogues targeted to bind the ”Zn2” site.
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Part I
Biological overview and methods
1
Chapter 1
Bacteria
The phenomenon of bacterial resistance against pharmacological treatment with
antibiotics has recently gained interest in scientific research, because it is becoming
a serious public health issue.
Penicillin was the first chemical compound able to inhibit bacterial growth,
and in some cases it is also able to cause lysis (named for that antibiotics). It was
isolated in 1928 by the biologist and pharmacologist Sir Alexander Fleming, who
immediately noticed the ability of bacteria to quickly develop resistance against
these drugs. The discovery of new similar compounds, and the modification of
the chemical structures of the already known antibiotics, allowed to initially cir-
cumvent the problem of resistance. Today a number of diseases, like tuberculosis,
gonorrhea, malaria, and childhood ear infections, have become hard to treat with
antibiotic drugs (http://www.fda.gov/oc/opacom/hottopics/anti resist.html)
During the 2002, the U.S. Centers for Disease Control and Prevention (CDC)
estimated that at least 90000 deaths a year only in the U.S. could be attributed to
bacterial infections, more than half caused by bugs resistant to at least one com-
monly used antibiotic [30]
Disease-causing microbes that have become resistant to drug therapy are an
increasing public health problem, that should be addressed soon.
1.1 Bacteria
In order to understand the biochemistry of resistance mechanism it is essential to
give a biological introduction on bacteria.
Not all the bacteria are dangerous organisms for the human health, on the coun-
trary, pathogenic bacteria are only a small portion of the bacteria as a whole. The
interest toward these microorganisms is vast and can span from control of disease
to biotechnology development.
Bacteria are microorganisms whose dimensions could range from (∼ 0.1 µm
to 500 µm), and which could have many different shapes (Fig. 1.1).
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Bacteria are prokaryotic organisms, which differ from eukaryotic cells of an-
imal and plants in many aspects: the most striking difference is that the former
do not posses a nuclear membrane, and the ”DNA material” is therefore in direct
contact with the cytoplasm, while in the latter a double-layered nuclear membrane
separates the genetic material from the cytosolic environment.
Another important difference is that all bacteria posses a biochemical structure,
called cell wall, that surrounds the external cytoplasmic membrane and provides
structural integrity to the cell, while this is rarely present in eukaryotic cells.
1.1.1 Bacteria growth and reproduction
In contrast to most eukaryotes, prokaryotes reproduce asexually. While sexual
reproduction in eukaryotes results in offspring with genetic material which is a
mixture of the parents X Y genome, a prokaryote will reproduce its own clones.
During reproduction, eukaryotes generate genetic variation by sexual recombina-
tion. Genetic variation mechanisms of prokaryotes are not tied to reproduction.
Prokaryotes are generally smaller than eukaryotes. The smallness has, among
other things, consequences for growth rates and generation times. Diffusion limita-
tion generally restricts the maximal size of prokaryotic cells. Because of the asex-
ual reproduction and short generation time relative to larger organisms, prokaryotes
pass the genome rapidly to subsequent generations. Therefore genetically changed
genomes are also rapidly transferred, and therefore prokaryotes swiftly adapt and
colonize new niches and a wide range of habitats.
Bacterial cell growth involves a co-ordinated increase in the mass of its con-
stituent parts, and usually leads to the division of a cell into two similar or identical
cells.
Figure 1.1: Schematic representation of various possible shapes of bacteria (not
drawn in scale).
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Bacteria grow only if their environment is suitable; if it is not optimal, growth
may occur at a lower rate or not at all, or in the worst case, they may die. Essential
requirements for growth include a supply of suitable nutriments, a source of energy,
water and appropriate temperature, pH value and level of oxygen.
In a growing cell there is a co-ordinated increase in the mass of the component
parts, where co-ordinated means that not all parts are made simultaneously: some
are synthesized more or less continually, but others are made in a definite sequence
during certain fixed periods. The cycle of events in which a cell grows and divides
into two daughter cells, is called the cell cycle.
Events that belong to this phase are: i) growth of cell’s dimension; ii) synthesis
of the cell envelope; iii) chromosome (DNA) replication; iv) septum formation (the
growing cell divides into two cells by the development of a cross-wall, which is the
septum).
All these represent the asexual reproduction of bacteria, also called binary fis-
sion (vertical gene transfer). In one bacterium, the single circular chromosome
duplicates. Then, the two resulting chromosomes attach to the inside of the plasma
membrane. The cell elongates and separates into two strands. Finally, the cell
membrane grows inward, the cell wall forms separating two daughter cells each
with a chromosome.
In binary fission, the genetic information is copied almost identically to cell
daughter. Mutations, and therefore evolution, are introduced randomly into the
genetic material. Other ways by which bacteria can blend their genes exhist, in
which new DNA elements may enter in a bacterium (horizontal gene transfer):
Transformation
In transformation, a bacterium takes up from its environment a piece of DNA;
one strand of this donor DNA is internalized and may genetically transform the
recipient cell by recombining with a homologous region of the chromosome (see
Fig. 1.2). Transformation occurs naturally in various Gram-positive and Gram-
negative bacteria, and it may contribute to the spread of antibiotic resistance in
pathogenic bacteria.
Conjugation
Certain (conjugative) plasmids, and conjugative transposons (mobile genetic
elements which can move from one DNA duplex to another) confer on their host
cells the ability to transfer DNA to other cells by conjugation; in this process, a
donor (male) cell transfers DNA to a recipient (female) cell, while the cells are in
physical contact (see Fig. 1.2).
Like transformation, conjugation can result in important phenotypic changes in
the recipient cell, like the acquisition of plasmid-encoded resistance to antibi-
otics.
Transduction
The transfer of DNA from one bacterial cell to another, via a bacteriophages
vector (a virus), is called transduction (see Fig. 1.2).
6 Bacteria
Figure 1.2: Horizontal gene transfer representation.
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1.2 Cell wall: the main target of antibiotics.
The typical cell envelope of a bacteria is made by two components, the cytoplasmic
membrane and, around it, the cell wall (Fig. 1.3).
Figure 1.3: Schematic organization of a typical bacterial cell
If a prokaryotic cell loses its cell wall, the result is a structure called protoplast,
and it can survive in a medium with the same salt concentration of the cytosolic
medium, and even carry out many of the normal processes of a normal living cell.
However, when immersed in a medium more diluted than the cytosol, water starts
to enter into protoplast, which starts to swell until it burst. Such phenomena is
called osmotic lysis. So, in an intact bacterium, the osmotic lysis is avoided by
mechanical strength of the cell wall.
The cell wall also prevents the protoplast by mechanical damage linked to
movement of bacterium in its environment, and it is responsible for its shape.
It also acts as a permeability barrier, regulating the transport of ions and molecule
(among which antibiotics) to move across the membrane.
Every species posses a cell wall that differs from the one of other species in
thickness, structure and composition. It is possible, however, to divide bacteria
in two major groups, according to the reaction of the cell to treatment of certain
dyes: one kind of cell wall, after being stained with, for example, crystal violet
or iodine, retains the colour even after wash of ethanol or aceton, the other kind
becomes decolorized. Based on this empirical procedure, bacteria that retain dyes
are called Gram positive, in honour of the scientist Christian Gram, who discovered
this procedure in 1880s, while the remaining ones are called Gram negative (Tab.
1.4).
The Gram-positive-type wall is made by a thick (from 30 to 100 nm) complex
polymer called peptidoglycan (murein), while the Gram-negative-type (20-30 nm
thick) posseses, in addition, another outer membrane (Fig. 1.4).
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Gram-positive Gram-negative
Bacillus Aeromonas
Clostridium Bacteroides
Lactobacillus Bordetella
Listeria Brucella
Propionibacterium Escherichia
Staphylococcus Haemophilus
Streptococcus Pseudomonas
Streptomyces Salmonella
Streptoverticillium Thiobacillus
Table 1.1: Major genera of Gram-positive and Gram-negative bacteria.
Figure 1.4: In Gram-positive bacteria (A), the cell wall is composed of a thick layer
of murein, while in Gram-negative bacteria (B) the murein layer is thinner but it is
surrounded by a second, outer lipid bilayer membrane.
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The peptidoglycan sacculus is a unique and essential structural element in the
cell of most bacteria, forming a closed, bag-shaped structure surrounding the cyto-
plasmic membrane.
The peptidoglycan scaffold of the bacterial cell wall is a repeating chain of two
aminosugars: N-acetylglucosamine (NAG) -N-acetylmuramic disaccharide (NAM).
A pentapeptide is attached to the D-lactyl moiety of each NAM (Fig. 1.5), and there
is a high diversity in the composition and sequence of the peptides from different
species, but it is worth to mention that in this biochemical structure one could find
one of the few examples by which nature exploits the D-chirality of aminoacids,
probably to escape the action of proteases degrading enzymes.
Figure 1.5: Chemical structure of the two building blocks of the peptidogly-
can chain, namely N-acetylglucosamine (NAG) and N-acetylmuramic disaccharide
(NAM), and the peptidic stem attached to NAM.
Each peptidoglycan monomer is synthesized in the cytosol of the bacterium,
and then attached to a membrane carrier molecule, called bactoprenol, which brings
the single monomers across the membrane and helps a number of other protein to
insert the new monomers into the existing peptidoglycan chain, thus enabling re-
generation of murein, and the growth of bacterium following binary fission.
The long sugar chains are then joined to one another by a peptide cross-link in
a net like structure with the required high strength to counterbalance the internal
osmotic pressure of the bacterium.
Murein posseses some striking biophysical properties: from one side it is a
powerfull structure able to withstand the internal turgor of bacteria up to 25 atm, but
from the other side the sacculi are flexible structures, allowing reversible expansion
under pressure and possesing wide pores that enable diffusion of large molecules
such as proteins.
1.3 Penicillin-binding proteins (PBP)
The polymerization of glycan chains (transglycosylation) and cross-linking of the
the glycan chains (transpeptidation) are catalyzed by the penicillin-binding proteins
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(PBPs) [31]
Bacteria posses a variable number of PBPs, which are divided into two main
categories, the high molecular mass and the low molecular mass PBPs.
PBPs share a common DD-peptidase activity (whether a DD-transpeptidase,
a DD-carboxypeptidase or a DD-endopeptidase activity) and are localized on the
outside of the cell membrane where peptidoglycan shynthesis takes place [32].
The carboxypeptidation and transpeptidation reactions catalyzed by PBPs follow a
three steps mechanism: (i) the rapid, reversible formation of a non covalent Henri-
Michaelis complex between the enzyme and a peptidoglycan stem pentapeptide
(L-Ala-γ-DGlu-A2pm (or L-Lys)-D-Ala-D-Ala), called the donor strand; (ii) sub-
sequent nucleophilic attack of the active serine on the carbonyl carbon atom of
the C-terminal D-Ala-D-Ala peptide bond, leading to the formation of an acyl-
enzyme intermediate and the concomitant release of the C-terminal D-Ala (acy-
lation); (iii) the final step (deacylation) consists of either hydrolysis, with release
of the shortened peptide (carboxypeptidation), or cross-link formation with a sec-
ond peptidoglycan stem peptide called the acceptor strand (transpeptidation). The
DD-endopeptidase activity of PBPs consists of the hydrolysis of the cross bridge
resulting from the DD-transpeptidase activity [33]. The DD-peptidase activity of
PBPs is catalyzed by a common PB domain which binds β -lactam antibiotics.
These drugs are aimed to competitively inhibit the enzymatic DD-peptidase ac-
tivity of this domain by playing on the structural similarity between penicillin and
the D-Ala-D-Ala dipeptide [34]. This ending the natural substrate of PBPs, the
pentapeptide precursor of the peptidoglycan.
Figure 1.6: The peptidoglycan net.
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1.4 β -lactam antibiotics
The common chemical structure among all antibiotics belonging to the so-called
class of β -lactams, is a 4 member cyclic amide, resulting from the fusion of a
lactone and an amide (Fig. 1.8).
β -lactam antibiotics comprise six different structural subtypes: penams, cephems,
monobactam, clavams, penems and barbapenem.
The penams include benzylpenicillin and ampicillin (Fig. 1.9).
The cephems include classical cephalosporins such as cephaloridine, nitrocefin
and cefotaxime, as well as cephamycins, which are 7-α-methoxy-cephalosporins
(Fig. 1.10). The monobactams are monocyclic β -lactams and include aztreonam.
1.4.1 Carbapenem
The main subject of this work is a selective carbapenemase enzyme, and there-
fore an introduction to this class of antibiotics is required. Latest generation of
β -lactam antibiotics are carbapenems, which have shown the broadest spectrum
of activity within this antibiotic class. They exhibit in vitro bactericidal activity
Figure 1.7: The reaction of transpeptidation catalyzed by PBP is represented on the
top part of the figure, while competitive inhibition by action of β -lactam antibiotics
is depicted on the bottom part.
Figure 1.8: The β -lactam ring.
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Figure 1.9: Some structures of most used penicillin antibiotics.
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Figure 1.10: Some structures of most used cephalosporins.
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against numerous pathogens, including Gram-positive and Gram-negative aerobes
and anaerobes (Fig. 1.11). In addition, carbapenems are stable to almost all β -
lactamases [16, 17, 18].
Figure 1.11: Carbapenem structures, in cronological order of discovery.
The carbapenems differ from penicillins (penams) in the presence of a carbon
atom replacing the sulphur at position 1, and an unsaturated bond between C2 and
C3 in the five membered ring structure.
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The broad spectrum activity of carbapenems is associated with their intrinsic
resistance to nearly all β -lactamases, which is due to the trans-α-1-hydroxyethyl
subtituent at the 6 position of carbapenems. This is unique when compared with
the side shains of penicillins and cephalosporins, which have cis configurations.
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Chapter 2
Metallo-β -lactamase (MβL)
enzymes
2.1 Mβ L: the zinc dependent lactamases
β -lactamases are the major cause of resistance of bacteria to β -lactam antibiotics.
These enzymes cleave the amide bond of the β -lactam ring, thus inactivating the
antibiotic. These enzyme fall in 4 classes: class A, C and D are serine-β -lactamases
which employ an active-site serine to catalyze hydrolysis, while metallo-β -lactamases,
or class B, are enzymes requiring one or two zinc ions for their activity. Metallo-
β -lactamases can degrade all classes of β -lactams, except monobactams and are
special for their constant and efficient carbapenemase activity. This is a most worri-
some characteristic because carbapenems, which are stable against the vast major-
ity of serine-β -lactamases produced by resistant pathogens, are the antibiotics with
the broadest spectrum of activity. Moreover, metallo-β -lactamases are not suscep-
tible to therapeutic β -lactamase inhibitors. The first of these enzymes, the Bacillus
cereus metallo-β -lactamase, was identified in 1996 when Sabbath and Abraham
showed that cephalosporinase activity produced by a B. cereus was inhibited by
EDTA [35]. During the two following decades it was the only known example
of metallo-β -lactamase, and was merely considered as a biochemical curiosity.
The situation changed after 1980. Indeed, zinc β -lactamases have been discovered
in an increasing number of nosocomial strains such as Bactroides fragilis [36],
Pseudomonas aeruginosa [37], Aeromonas hydrophila [38], Serratia marcescens
[39] and Elizabethkinggia meningoseptica [40]. The emergence and dissemina-
tion of acquired metallo-β -lactamases, encoded by genes carried on mobile DNA
elements, among major Gram-negative pathogens, made the situation even more
worrying [11]. Moreover, many metallo-β -lactamase genes are present in en-
vironmental species with thus constitute reservoirs of β -lactam resistance genes
[41, 42, 43, 44].
The class B β -lactamases are classified into three subclasses B1, B2 and B3 on
the basis of sequence alignments [45]. The classification task was complicated by
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the generally low degree of similarity between subclass sequence, but facilitated
by the availability of X-ray structures (Fig. 2.2), this allowed the identification of
corresponding secondary structures elements, even when the sequence similarity
was not obvious. The standard numbering of class B β -lactamases (BBL) allows
easy comparison of the sequence of these enzymes [45]. Subclass B1 enzymes
share more than 23% sequence identity. These enzymes includes the prototypi-
cal BcII from B. cereus [46], BlaB from E. meningoseptica [40] and EBR-1 from
Empedobacter brevis [47]. The acquired IMP-type MβLs found in some clinical
isolates of P. aeruginosa [48], S. marcescens [39], Klebsiella pneumoniase and
Acinetobacter baumannii [17], as the VIM-type or SPM-1 enzymes produced by
different species of Aeromonas (the most studied are CphA produced by A. hy-
drophila [38] and Imis produced by A. veronii [49] ) as well as the Sfh-I enzyme
produced by Serratia fonticola [42].
Subclass B3 metallo-β -lactamases has only nine conserved residues when com-
pared with the other metallo-β -lactamases. Subclass B3 inlcude the L1 and GOB-
1 metallo-β -lactamases produced by clinical strains of S. maltophilia [50] and E.
meningoseptica and FEZ-1 isolated from Legionella gormanii [51]. To date, 18
variants of GOB-1 have been reported, but none outside the E. menincoseptica
species. In the GOB enzymes, His116 is replaced by a glutamine. With the excep-
tion of L1 which is a homo-tetramer [15], all these enzymes are monomeric as the
B1 and B2 enzymes. B1 and B3 members are broad spectrum enzymes and hy-
drolyze most β -lactam antibiotics including carbapenems [52], only the monobac-
tams are neither hydrolyzed nor recognized by these enzymes, which moreover are
not inhibited by classical inhibitors of serine-active β -lactamases such as clavu-
lanic acid and tazobactam. These compounds, in fact, behave as poor substrate.
Table 2.1: Kinetic parameters determined for MβLs [52].
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The subclass B2 enzymes are high selective carbapenemases [52, 53, 49]. They
only hydrolyze carbapenems efficiently and show a very weak activity, if any, to-
wards penicillins and cephalosporins. In B2 enzymes, the conserved His116 of B1
and B3 enzymes, is replaced by an asparagine. The presence of this asparagine in
position 116 is far from being the only reason which explains the narrow spectrum
of B2 metallo-β -lactamases, since, although increased, the activity of the H116N
CphA mutant towards penicillins and cephalosporins remains low [54].
A mutant of CphA with a considerably broadened activity spectrum, N116H-
N220G was recently obtained by site-directed mutagenesis [55]. In contrast to
the wild-type enzyme, this mutant is able to efficiently hydrolyze penicillins and
cephalosporins in addition to carbapenems, although with a reduced efficiency to-
wards the latter.
Subclass B1 and B2 are descended from a common ancestor, and really form a
single group within which the sequences exhibit significant similarities. Subclass
B3 shares structural but not sequence similatrities with B1/B2 groups [56]. A
phylogenetic tree with representative members of all the three subclasses is given,
to revise the classification of metallo-β -lactamases [57].
The three dimensional structure of the mono-zinc form of BcII was the first
to be solved [58]. Thereafter, the structures of other subclass B1 enzymes, CcrA
[59], the di-zinc form of BcII [60], IMP-1 [61], VIM-2, SPM-1 [62] and subclass
B3 enzymes, L1 [15], FEZ-1 [63] and BJP-1 were determined. More recently,
the structure of a subclass B2 enzyme, CphA, was solved [14]. Despite of the
low level of identity between the amino acid sequences, the general fold of these
enzymes is similar and consists of an αββα structure, composed by two central
β -sheets with five solvent exposed α-helices. The N-terminal and C-terminal parts
of the molecule, each of them comprising a β -strand and two α helices, can be
superposed by a 180deg rotation around a central axis, suggesting that the complete
structure might have arisen from the duplication of a gene [60]. In all known
structures, the active site is located at the external edge of the ββ sandwich. The
N-terminal domain of B1 metallo-β -lactamases incorporates a loop (61-65) that
can interact with substrate or inhibitor molecules which possess hydrophobic side-
chains. This loop is very flexible in the native form of the enzyme. When the
substrate or the inhibitor diffuses into the active site, the loop moves to block the
molecule ( the side chain of the W64 residue interacts with the hydrophobic side
chain of the substrate [64]). The loop is also stabilized upon binding of inhibitors
[59, 63] and transforms the active site groove into a tunnel-shaped cavity. The
deletion of this loop (named flap) seriously affects the enzymatic activity, with the
only exception of thje activity towards imipenem. Actually, the kinetic parameters
of this carbapenem compound are barely affected by the absence of the active site
loop. The main difference between the carbapenems relies on the fact that they
usually have bulky aromatic ring substitutions which are absent in the former.
The 61-65 flap is absent in β -lactamases of subclasses B2 and B3.
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2.2 CphA: the first crystal structure of a mononuclear B2
Mβ L
2.2.1 The free enzyme
Garau and coworkers [14] solved the first crystallographic structure of the enzyme
CphA, from Aeromonas hydrophila in 2004.
This enzyme consists of 227 amino acid residues with a calculated molecular
mass of 25.2 kDa. The model of the structure includes 224 amino acid residues
(41-304, using the standard class B β -lactamase numbering [45]), the catalytically
essential zinc ion, one carbonate anion located in the active site, one sulphate ion,
and 178 water molecules.
CphA is a monomeric globular protein having the general αββα fold as de-
scribed in Fig. 2.1
Figure 2.1: X-ray secondary structure of CphA from Aeromonas hydrophila.
Four β -strands (β1, β2, β3 and β4), two helix-strand elements (α1β5 and
α2β6), one long α-helix (α3, and the β7 strand form the N-doman, while four β -
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strands (β8, β9, β10 and β11), one 310 helix, the α4 helix, the β12 strand, and the
α5 helix form the C-domain. The N and C-domains face each other through sheets
β1-7 and β8-12. The α1 and α2 helices of the N-domain are located externally on
opposite faces of the β -strand core. In contrast to all reported B1 and B3 structures,
a long α3 helix, formed by residues Arg140-Leu161, has a kink, which allows the
helix to follow the curvature of the protein. The helix is followed immediately by
an unusual proline-rich loop (Pro162, Pro165, Pro168 and Pro172) (Fig. 2.2).
Figure 2.2: Secondary structure of members of each MβL subclass.
The ψ ,φ angles of Tyr 60, Thr86, Ala195, Asn220 and Asp264 are located
in the disallowed areas of the Ramachandran plot. The last three are adjacent to
an amino acid involved in one of the zinc-binding sites (”Zn1” or ”Zn2”) and, in
most other sequences, are glycine residues. Tyr60 is on a loop connecting two β -
strands (β2 and β3), which forces it to adopt a strained conformation (ψ = 58deg;
φ =−123deg ). Thr86 is on a loop connecting β4 to α1, and is adjacent to Trp87.
A group of hydrophobic side-chains (Tyr59, Val67, Trp87, Tyr164, Pro165 and
Phe236), together with other side-chains located on the α3 helix (Ile153, Phe156
and Leu161), appears to form a ”hydrophobic wall”, which defines the active site.
Ala196 (ψ = −160deg; φ = −160deg ) is located on a loop between strands β8
and β9, which, at its apex bears His196, which is involved in the active-site hydro-
gen bond network. Asn220 is the first residue of the 310 helix and precedes the zinc-
coordinating residue, Cys221, while Asp264 follows another zinc-coordinating
residue, His263.
Secondary structure elements bear two of the three residues involved in zinc co-
ordination, Asp120 in the α2 helix and Cys221 in the 310 helix. The third residue,
His263, is located on the loop connecting β12 and β13. The distances betwen
the Zn atom and the Asp120 carboxyl oxygen atom, the Cys221 sulfur atom, and
His263 side-chain nitrogen atom are 1.96A˚, 2.20A˚ and 2.05A˚, respectively. Fi-
nally, a carbonate ion is bonded to the zinc (2.09 A˚), and the four coordinating
atoms, from Asp120, Cys221, His263, and O1 of CO2−3 , generate a tetrahedral
geometry around the metal ion.
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2.2.2 The CphA-biapenem complex
Figure 2.3: Close up of the X-ray structure of CphA from Aeromonas hydrophila,
in complex with biapenem derivative.
The importance of experimental data of Garau et al. relies not only to have
solved for the first time a B2 MβL structure, but to succeed also in obtaining a
structure of the complex with an antibiotic (Fig. 2.3). The refined CphA-biapenem
complex structure comprises 227 protein residues, one zinc ion, six sulphate an-
ions, and the biapenem molecule located in the groove of the active site with full
occupancy. In [14] the author called this modified biapenem ”intermediate” of the
reaction, but it is still not clear if this is in fact an intermediate, or a modification
of the reaction products that back-acts as inhibitors in the catalytic pocket. In this
work I will refer to it as ”biapenem derivative” (Fig. and Fig. 2.4).
The biapenem derivative is bonded to the zinc ion located at the WT position.
The distance from the nitrogen atom of the β -lactam ring (N4) to the Zn2+ is 2.22
A˚. N4 also forms a hydrogen bond with Wat1 (2.9 A˚), which in turn, forms hy-
drogen bonds with Asp120 and His118. The distance between Wat1 and the zinc
atom is 3.39 A˚. The β -lactam ring, as emerged from electron density map, has been
cleaved between N4 and C7. The C3 carboxyl group forms strong hydrogen bonds
wih the Lys224 side-chain nitrogen atom and the Asn233 backbone nitrogen atom.
The C7 carboxyl group formed after antibiotic hydrolysis makes two hydrogen
bonds with the two hydroxyl groups of Thr119 and Thr157. C2 and C3 of the bia-
penem derivative exhibit sp3 hybridization, showing that the molecule in the active
site has lost the C2=C3 double bond. The side-chain containing the sulphur atom
and the C3 carboxyl group are in cis configuration. The biapenem is hydrolyzed
and has lost the double bond, and it has an internal molecular rearrangement. The
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biapenem derivative in the active site is stabilized by several hydrophobic contacts.
The biapenem sulfur atom interacts with the His263 ring, inducing a small rotation
of its plane; the 1β -mehyl group is in van der Waals contact with the side-chain of
Trp87 and Val67, and the methyl group of the C6 1-hydroxyethyl forms hydropho-
bic contacts with Phe156 and Phe236 and the Asn233 sidechains carbon atoms.
2.2.3 Zinc coordination
Metallo-β -lactamases posses two potential Zn2+ binding sites (Fig. 2.5).
Figure 2.4: Schematic representation of the active site of CphA in complex with
biapenem derivative (PDB 1X8I [14]).
Figure 2.5: ”Zn1” and ”Zn2” binding sites in MβLs, as observed in the B1
BCII enzyme from Bacillus cereus [13] (residues are cut at the Cα), the B2
CphA enzyme from Aeromonas hydrophila [14] and the B3 L1 enzyme from
Stenotrophomonas maltophilia [15]. In the case of the B1 enzyme, a second sol-
vent molecule binds to the metal ion. The backbone units of the residues are not
shown for clarity.
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In the case of B1 enzymes, one zinc ion possesses a tetrahedral coordination
sphere and is coordinated by His116, His118, His196 and a water molecule or
OH− ion. The other metal ion has a trigonal-pyramidal coordination sphere which
invloves Asp120, Cys221, His263 and two water molecules. One water/hydroxide
molecule servers as a ligand for both metal ions. The two binding sites are named
”Zn1” and ”Zn2” binding site, or with a letter code which indicates the ammi-
noacidic composition of the site (so that one is called 3H site, while the second
DCH site).
In B3 enzymes the 3H site is the same as that found in B1 enzymes. Cys221
is replaced by a serine and the second zinc ion is coordinated by Asp120, His121,
His263 and the nucleophilic water molecule which forms a bridge between the two
metal ions. Ser221 does not directly interact with the zinc ion but with a second
water molecule located in the active site and which could serve as proton donor in
the catalytic process [15]. In contrast to all other related metallo-β -lactamases, the
subclass B3 GOB-18 enzyme is fully active against a broad range of β -lactam sub-
strate as a mono-zinc species. Different spectroscopic techniques, 3D modelling
and mutagenesis experiments, reveal that the zinc ion is bound to Asp120, His121,
His263 and a solvent molecule, which means in the canonical ”Zn2” site of B3
subclass [65].
While the B1 and B3 enzymes exhibit maximum activity as di-zinc species, the
B2 β -lactamases are inhibited upon binding of a second Zn2+ ion (for CphA, the
dissociation constant Ki is 46 µM at pH 6.5 [66]).
In agreement with EXAFS spectroscopy studies [67] and site directed muta-
genesis [54], the crystallographic structure of CphA shows that the zinc ion is in
the ”Zn2” site, namely a DCH site [14]. Currently, the identification of the second
binding site in subclass B2 enzymes remains unsettled since even in the presence
of a large excess of zinc (up to 10 mM) and in spite of the low value of the disso-
ciation constant, Garau and his coworkers did not succeed in obtaining crystals of
the di-zinc form. On the basis of spectroscopic studies with the cobalt substituted
ImiS enzyme, Crawford et al. postulate that in subclass B2 the second metal bind-
ing site is not the traditional ”histidine” site [68]. Costello et al. propose that in
ImiS the inhibitory zinc ion binds to both His118 and Met146 [69]. Indeed, their
EXAFS data show that the inhibitory zinc is bound by a sulphur. Such sulphur in
the inhibitory site should come from a methionine, because the only other sulphur-
containing residue is Cys221, yet involved in the bind of Zn(II) in the catalytic site.
Moreover, M146I mutation abolishes inhibition induced by zinc. However, muta-
tions of other CphA residues, which have not been implicated as ”Zn2” ligands can
have similar effects (lower inhibition or even activation by excess of zinc) [54, 55].
2.2.4 Mono vs di nuclear enzymes
The subclass B2 CphA enzyme exists mainly in the mono-zinc form as the value
of the dissociation constants are 200 nM and 46 µM, respectively for the binding
of the first and the second zinc ion [66]. Subclass B1 metallo-β -lactamases show
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distinct stereochemical similarities in their active sites, with identical residues con-
tributing to metal coordination. However, the corresponding zinc affinities appear
to be different, so that CcrA and IMP-1 show two high-affinity metal-binding sites,
whereas BcII binds ”Zn1” and ”Zn2” with very different affinities. Fluorescence
spectroscopy studies with a chromophoric chelator show that BcII has very differ-
ent dissociation constant for the two metal-binding sites. For the loss of metal-ion
from the mononuclear enzyme, the dissociation constant Kmono is 6.2 x 10−10 M
and that for the loss of one metal-ion from the dinuclear MβL, Kdi is 1.5 x 10−6
M [70]. Kmono decreases significantly, from nanomolar to picomolar values, in the
presence of substrate, whereas Kdi decreases only twofold [71]. This suggests that
the mono-zinc enzyme is responsible for the catalytic activity under physiological
conditions, where the concentration of free zinc ions is found by crystallographic
methods in the 3H site, at pH 5.6, in presence of 100 µM zinc [58]. At this pH,
the activity is only three- to fourfold lower than that at pH 7.5 [72]. But the ex-
istence of the mononuclear form, where the metal ion would be shared between
the two binding sites is supported by several kinetic results, PAC (Cd) and spec-
troscopic (Co) data [70]. Conversely, and despite the very close similarity with
BcII, the B1 enzyme CcrA binds both zinc ions very tightly. Kinetic studies of
CcrA with nitrocefin have shown that only the di-nuclear species is active and that
a previously observed mono-zinc CcrA enzyme [73] was a mixture of the di-zinc
and the apo-enzyme [74]. BcII is active in the presence of either one or two zinc
ions, although full activity is observed when two zinc ions are bound. It has been
proposed that the arginine 121 present in BcII, Vim-2, BlaB and in subclass B2
enzymes is responsible for the lower affinities. The CcrA and IMP-1 enzymes,
showing high affinity for both zinc ions, have cysteine and serine, respectively, in
the corresponding position. The replacement of the positive Arg121 side chain in
CphA by a neutral one enhances the affinity for Zn2+ [55], as was already sug-
gested for BcII [58, 75]. Rasia and Vila [76] have shown that R121H mutation
increases the affinity for the second Zn2+. The C121R mutant of CcrA was iso-
lated in the di-zinc form, although the removal of the second zinc appeared to be
facilitated [74]. All these data indicate that the replacementt of Arg121 by a neu-
tral residue (a Cys, Ser or His, respectively) in CcrA, IMP-1, and the subclass B3
enzymes increases the affinity for the second zinc. Until recently, no mono-zinc
form of subclass B3 enzymes was observed. However, the subclass B3 GOB-18
was shown to be a mononuclear enzyme [65].
As shown by the data described above, the activity and even the existence of
mono-zinc forms of B1 and B3 enzymes remain controversial. It seems impossibile
to supply a clear answer to these issues and it is possible that minor sequence
differences might result in different behaviours. For B2 enzymes, the mono-zinc
form is clearly the active one, but here the location of the inhibitory second zinc
remains unknown.
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2.2.5 Catalytic mechanism of MβLs
It is supposed that the β -lactam hydrolysis occurs in two steps: the nucleophilic
attack on the carbonyl group and C-N bond cleavage, this second step being gen-
erally triggered upon protonation of the nitrogen. The bicyclic shape of β -lactams
requires that the two steps take place on the same face of the antibiotic [72].
The nature of the attacking nucleophile in the three subclasses is dependent on
the nature of Zn ligand in the catalytic pocket. This is related to the open issue of
the exact location of the Zn in the mononuclear form, but it seems most likely to
be a ”Zn1”-bound hydroxide in mono and dinuclear B1 and B3 MβLs.
2.2.6 Dinuclear MβLs
The best understood dinuclear MβLs are CcrA, IMP-1 and L1. Nitrocefin was
used as substrate in most of the studies. This is a chromophoric cephalosporin that,
although with no therapeutic utility, undergoes intense spectroscopic changes upon
hydrolysis making it a useful mechanistic probe.
Stopped-flow kinetic studies of nitrocefin hydrolysis by L1 and CcrA revealed
the accumulation of ring-opened, anioinc intermediate [77, 78]. This species has
been observed in nitrocefin hydrolysis by a diZn(II) model complex [79] and its
existence is supported by computational studies [26]. Taken together these data
indicate that Zn2 stabilizes negative charge on the nitrogen atom after C-N bond
cleavage. Rapid-freeze quench EPR studies on Co(II)-substituted L1 demonstrate
that changes in the geometry of Co2 occur when this intermediate is formed and
that similar changes come along with the other β -lactams [80]. However, the de-
gree of accumulation of this intermediate varies markedly between enzymes and
depends upon the protein environment. Nitrocefin differs from the majority of
therapeutic β -lactams in possession of an extended pi-conjugated system that con-
tributes to the stabilization of an anioinc nitrogen. Studies of a wider range of sub-
strates have led Spencer and coworkers to suggest that, in most cases, the amide
bond is still intact in the populated enzyme-bound species [81]. Nitrogen protona-
tion and C-N bond cleavage may not be distinguishable as two separate steps with
other substrates (Fig. 2.6).
The general reaction mechanism for dizinc MβLs, emerging from all previ-
ous works (Fig. 2.6) could be described with the following events: after a rapid-
equilibrium binding of substrate [81], the bridging hydroxide becomes terminal as
the β -lactam carbonyl interacts with ”Zn1” [82, 27].
The β -lactam carbonyl is polarized by the metal and also by other residues,
and it is therefore susceptible to nucleophilic attack [26]. Deprotonated Asp120
orients the hydroxide to attack the β -lactam carbonyl carbon, generating a tetrahe-
dral species [26, 27, 83, 84] that, in contrast to the serine catalyzed β -lactamases,
does not seem to accumulate.
This species collapses into a nitrogen-anionic intermediate that yields to prod-
uct upon protonation [85]. This intermediate was postulated to be the species de-
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Figure 2.6: Cephalosporin hydrolysis catalyzed by (A) binuclear MβL CcrA from
B. fragilis and (B) Mononuclear BcII from B. cereus [23].
28 Metallo-β -lactamase (MβL) enzymes
tected in stopped-flow UV-Vis studies of nitrocefin hydrolysis [86]. Breakdown
of either the tetrahedral or the nitrogen-anionic intermediate may be rate-limiting,
depending on the substrate and the identity of the amino acids in the active site
[74, 81, 87, 88]. The crystal structure of the L1 in complex with hydrolyzed mox-
alactam complex supports a role for ”Zn2” in stabilizing the transient development
of negative charge on the bridging nitrogen [89]. Asp120 and a water molecule
have been suggested as possible proton donors in the rate-determining step, al-
though this issue is still matter of debate. Mutagenesis studies of Asp120 reveal
that this residue is essential in CcrA, L1, IMP-1 and BcII [87, 90, 84, 91]
2.2.7 Mononuclear B1 MβLs
In the proposed mechanism for mono-Zn(II) BcII, the resting form of the enzyme
is assumed to be the tetrahedral ”Zn1” site. The Zn(II)-bound water/OH- is hy-
drogen bonded to deprotonated Asp120, His263 and Cys221 [92, 93, 83]. Asp120
is oriented by Arg121 via two hydrogen bonds. Both kinetic studies of the pH
dependence of β -lactam hydrolysis [72] and crystallographic results [93] support
the hypothesis that the pKa of the Zn(II)-bound water is 5.6. As in dinuclear
MβLs, this hydroxide serves as the reaction nucleophile, being oriented by Asp120
[94, 22]. During breakdown of the tetrahedral intermediate, proton transfer to the
β -lactam nitrogen is required. The source of this proton is not clear; however,
His263 [28, 24], Asp120 [72], and a water molecule [22] have been implicated as
potential proton donors. As recently predicted with L1 [84], Asp120 may play a
role in orienting water for proton donation. Mono-Zn(II) BcII is not thought to
stabilize anionic intermediates.
Mononuclear B2 MβLs: CphA
Based on structural information gained by X-ray structure of the complex CphA-
biapenem [14], Garau et al. proposed a specific reaction pathway, outlined in Fig.
2.7.
In the structure of the complex, the C3 carboxyl group makes a bond with the
zinc ion, and interacts with the NH+3 of Lys224, and the Asn233 nitrogen back-
bone. Thr119 and Thr157 form hydrogen bonds with, and Phe156 and Phe236
form hydrophobic interactions with, the hydroxyethyl group, which helps to stabi-
lize and orient the antibiotic molecule. Substrate binding promotes the polarization
of the β -lactam ring carbonyl oxygen atom by His196. The Asn116 side-chain ni-
trogen atom and Thr197 hydroxyl group form hydrogen bonds with the His196
sidechain nitrogen atom. This hydrogen bonding network allows His196 to par-
tially donate its hydrogen atom to the β -lactam ring carbonyl oxygen atom. A
water molecule, activated by His118, attacks the carbonyl carbon and cleaves the
β -lactam bond. As a consequence N4 of carbapenem bonds to the zinc. The Zn2+
also helps in the correct orientation of the β -lactam ring during hydrolysis. The car-
boxyl group, generated by the hydrolytic process, is stabilized initially by His196,
Asp120 and His118, but after rotation around the C5-C6 bond, these interactions
are replaced by these observed in the complex between the carboxyl group and
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Thr119, Thr157. The water molecule Wat1 is located in a position suitable for
promoting the protonation of the lactam nitrogen atom, which will weaken the in-
teractions with the Zn(II). At the last step of the catalytic reaction, the hydrolyzed
carbapenem molecule can leave the active site.
Recent SCC-DFTB calculations [95] on the CphA enzyme were consistent
with the postulated first step of reaction, identifying Asp120 as general base [96,
97]. The calculated free energy barrier for this step would be consistent with exper-
imental data [14], if such step is the rate-limiting one, along the enzymatic cycle.
This at present is not known, since the second step has not been yet investigated. In
the same computational study, it was speculated that the β -lactam N(1) would ac-
cept a proton directly from Asp120 (path II in Fig. 5.1) with consequent breaking
of the C-N bond.
Figure 2.7: Reaction pathway proposed based on X-ray structural data of CphA in
complex with biapenem derivative [14].
2.3 Enzyme Kinetics Theory
A quick introduction on the theory of enzymatic kinetics is given in order to explain
the two experimental quantities kcat and KM with which we have compared our
computational results.
We will always assume, in every derivation of kinetic equations, that the con-
centration of the substrate [S] is larger than [E], or that the latter is negligible with
respect to the first. Such assumption is really close to reality, because of the high
catalytic efficiency of the enzymes.
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2.3.1 Michaelis-Menten mechanism
The Michaelis-Menten is the most simple mechanism that one could assume for an
enzymatic reaction, and proceeds according to the following the scheme:
E + S
KS
⇋ES kcat→E + P (2.1)
The above equation assumes that the substrate and enzyme combine rapidly
and reversibly, via non-covalent interactions, to form the complex ES, also called
Michaelis-complex. The chemical reaction occurs in a second step, with a first-
order rate constant kcat (the turnover number). From 2.1
[E][S]
[ES] = KS (2.2)
and
ν = kcat [ES] (2.3)
We define the total enzyme concentration [E]0, which is related to the free
enzyme [E] by:
[E] = [E]0− [ES] (2.4)
thus
[ES] = [E]0[S]
KS +[S]
(2.5)
and finally
ν =
kcat [E]0[S]
KS +[S]
(2.6)
2.3.2 Experimental basis
It is found experimentally that there is a direct proportionality between ν and [E]0,
that is, as we have already seen, the total enzyme concentration.
Usually it is observed that ν follows a saturation kinetics with respect to [S],
similar to the one plotted in 2.8.
All this is expressed by the experimental equation:
ν =
kcat [E]0[S]
KM +[S]
(2.7)
The saturating limit towards which ν tends as the substrate concentration in-
creases, is Vmax = kcat [E]0. We also define KM to be the substrate at which ν =
1
2Vmax, and finally we note that at very low [S], or at least at [S]≪ KM, we have:
ν =
kcat [E]0[S]
KM
(2.8)
.
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Figure 2.8: Reaction rate plotted against the substrate concentration
2.3.3 Extension of the Michaelis-Menten mechanism
The Michaelis-Menten mechanism derived before is just a particular case of the
general mechanism that is valid when k2 ≪ k−1:
E + S
k1
⇋
k−1
ES k2→E + P (2.9)
.
We solve this equation applying the steady state approximation to [ES]
d[ES]
dt = 0 = k1[E][S]− k−1[ES]− k2[ES], (2.10)
we remember that [ES] = [E]0− [E],
which leads to
[ES] = [E]0[S]k2+k−1
k1 +[S]
, (2.11)
and, since ν = k2[ES]
ν =
[E]0[S]k2
k2+k−1
k1 +[S]
(2.12)
we call KM = k2+k−1k1 , and remembering also that KS =
k−1
K1 we have
KM = KS +
k2
k1
(2.13)
Now it is clear that in the case of k−1 ≫ k2 we have the simplification KM = KS
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Methods
The computational tools, used in this work to address the study of the important
class of MβL enzymes, will be presented in this chapter.
3.1 A protein floating in water: the physical system
From the physical point of view, the system we have faced in this study (a pro-
tein immersed in a water medium), can be considered as a collection of interacting
atoms (i.e. atomic nuclei surrounded by electronic clouds). Movements and recip-
rocal interactions can be described by quantum mechanics formalism: the system
of M nuclei and N electrons is described by a wave-function Ψ(R,r, t), which is
a function of the 3M nuclear (R), 3N electronic (r) coordinates, and of time (for
simplicity we will not consider nuclear and electronic spin degree of freedom, and
spin coupling effects).
In a non-relativistic description, this wave function should solve the Schro¨dinger
Equation:
ih¯ ∂∂ t Ψ =
ˆH Ψ, (3.1)
where ˆH , the Hamiltonian, in the absence of external forces, is given by the
general form:
ˆH = −
M
∑
I=1
h¯2
2MI
∇2I −
N
∑
i=1
h¯2
2m
∇2i +
e2
2
M
∑
I=1
M
∑
J 6=I
ZIZJ
|RI −RJ|
+
e2
2
N
∑
i=1
N
∑
j 6=i
1
|ri− r j| −
e2
2
P
∑
I=1
N
∑
i=1
ZI
|RI − ri| , (3.2)
where Z and M are the nuclear charges and masses, m is the electronic mass.
Temporal and spatial coordinates could be separated, and 3.1 could be simpli-
fied into a time-independent formulation, which is an eigenvalue equation:
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ˆH Ψn(R,r) = EnΨn(R,r). (3.3)
In practice, only few trivial cases, like hydrogenoid atoms or H+2 molecule,
could be analytically solved within a full quantum mechanical framework. Exact
numerical solution covered for some more cases, but the number of ”solvable sys-
tems” remains small. Several features contributes to this difficulty, but the most im-
portant is the two-body nature of the Coulomb interaction, which introduces high
correlations between the degrees of freedom, making 3.3 a not-separable equation.
There are many approximations that could be used in order to conform 3.3 into
a separable form that can be solved. I will present the approximation considered to
be the cornerstone of the computational chemistry.
3.1.1 Adiabatic approximation
A straightforward simplification could be introduced, which arises from the ob-
servation that time scales associated with the motion of electrons and nuclei, are
different. Namely nuclei move much slower than electrons: due to the small mass
ratio between nuclear and electronic mass. In the hydrogen case, which represents
the lower limit of this approximation, is less than 1/1836.
Based on this consideration, Born and Oppenheimer (1927) proposed a scheme
for separating the nuclear and electronic variables, and showed that, under appro-
priate condition, no mixing of different electronic stationary states occurs due to
interaction with the nuclei. In other words the electrons do not undergo transition
between stationary states (adiabatic approximation). In this framework, the elec-
trons could be thought as instantaneously following the motion of the nuclei, while
remaining always in the same stationary state of the electronic Hamiltonian. This
means that as the nuclei follow their dynamics, the electrons instantaneously ad-
just their wave functions according to the nuclear configuration (i.e. nuclear wave
function).
In mathematical language, one could take as solution of 3.3
Ψ(R,r, t) = ∑
n
Θn(R, t)Φn(R,r), (3.4)
where Θn(R, t) are wave functions describing the evolution of the nuclear sub-
system, in each of the adiabatic electronic eigenstate Φn(R,r).
These satisfy the time-independent electronic Schro¨dinger equation
ˆheΦn(R,r) = En(R)Φn(R,r), (3.5)
where the electronic Hamiltonian is:
ˆhe = ˆT + ˆUee + ˆVee = ˆH − ˆTn− ˆVnn (3.6)
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where ˆT is the electronic kinetic operator, ˆUee is electron-electron interaction,
ˆUee, ˆVne the electron-nuclear interaction, ˆTn and ˆVnn the inter-nuclear interaction
potential operator.
By replacing the ansatz 3.4 into the Schro¨dinger equation, after some calcula-
tions, one ends up with mixed terms of the type
∫
Φ∗q(R,r)∇IΦn(R,r).
Therefore, the reduction of the full wave function to an expression like
Ψ(R,r, t) = Θn(R, t)Φn(R,r), (3.7)
is still not completely correct, because even if a system is initially prepared in a
pure, the off-diagonal terms will excite different electronic eigenstates along tem-
poral evolution. These terms could be neglected, if the following condition is sat-
isfied:
m
M
∣∣ h¯ΩV
Eq(R)−En(R)
∣∣≪ 1 (3.8)
where ΩV is the maximum frequency of rotation of the electronic wave func-
tion due to the nuclear motion. Under these conditions, the Born-Oppenheimer
approximation allows to pass from a N+M many-body problem, to the solution of
the N electrons problem at fixed nuclear positions, and then to the solution of M
nuclei problem, which move in a field generated by the N electrons (in absence of
external fields).
Solving the electronic Schro¨dinger equation in a many-body is one key issue
in physics, and many theories were developed to this aim. In the next section we
will review one of the most important ones, which allows to treat relatively large
systems at a reasonable computational cost.
3.2 Density Functional Theory
DFT is rigorous theory of the ground-state of many-particle system has gained in
the last twenty years an important role in the computational science. The main idea
beyond that approach exploits the one-to-one mapping between N particle density
(ρ(r)) and the wave function of the N particle system.
This approach posseses two advantages:
i) the reduction of dimensionality of the problem from 3N variables into 3 (the
spatial coordinates r
ii) the use of a quantity (ρ) which is an observable easy to measure and visual-
ize.
The Hohenberg-Kohn theorems
DFT theory is based on two theorems enunciated by Hohenberg and Kohn in 1964
[98]. The first one provides a justification for the use of density: if one consider
a system with a Hamiltonian, which is characterized by an external potential Vext ,
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and the density ρ(r), this theorem states: the external potential Vext is determined,
within a trivial additive constant, by the electron density ρ(r) .
Since the density determines the Hamiltonian, and also the number of electrons,
it follows that ρ determines the ground-state wave function, and therefore all the
observables of the system.
The second theorem provides a variational principle for the ground-state den-
sity: given any trial density ρ˜ > 0 for which
∫
ρ˜(r)dr = N, it follows that E[ρ˜] ≥
E[ρ ]. From this result, one can get a variational equation to obtain the ground-
state energy. Applying the Hohenberg-Kohn theorem to a system of N electrons in
which the external potential is due to the nuclei, the energy in terms of the elec-
tronic density reads:
E[ρ ] = Te[ρ ]+Vee[ρ ]+Ven[ρ ]+Vnn = F [ρ ]+
∫
drρ(r)Vext (3.9)
where F[ρ ] = Te[ρ ] +Vee[ρ ] = 〈ψ |Te +Vee|ψ〉 is a universal functional inde-
pendent from the external potential Vext [ρ ] = VeN [ρ ]+VNN .
Applying to ρ the stationary principle
δ
{
E[ρ ]−µ[∫ ρ(r)dr−N]}= 0, (3.10)
we obtain the Euler-Lagrange equation for the multiplier µ :
µ = Vext(r)+
∂F[ρ ]
∂ρ (3.11)
The application of the variational principle requires in practice an explicit for-
mulation of the functional F, which is not known in term of electron density.
3.2.1 The Kohn-Sham equations
The two theorems were also re-formulated into a suitable form to be computation-
ally treatable. To this aim, Kohn and Sham propose the idea of mapping the system
of N interacting particles into an equivalent one of non-interacting bodies, which
is characterized by exactly the same ground-state density.
In that case, the density turns out to be expressed as a summation over single-
particle contributions
ρ(r) =
N
∑
i=1
|ϕKSi (r)|2, (3.12)
and the kinetic energy functional has a simple analytical expression:
T0[ρ ] =
N
∑
i=1
〈ϕKSi |−
1
2
∇2|ϕKSi 〉. (3.13)
The functional F[ρ ] can be rewritten as:
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F[ρ ] = T0[ρ ]+VH [ρ ]+ Exc[ρ ] (3.14)
where VH = 12
∫
dr’ ρ(r)ρ(r’)|r-r’| is the classical part of the particle-particle interac-
tion, and the ‘exchange-correlation’ functional Exc is defined as:
Exc[ρ ] = T [ρ ]−T0[ρ ]+Vee[ρ ]−VH [ρ ] (3.15)
Formally Exc can be written in terms of an exchange-correlation energy per
particle εxc, which is itself functional of the total density:
Exc[ρ ] =
∫
drρ(r)εxc[ρ ] (3.16)
Equation 3.11, turns out to be:
µ = V KS(r)+ ∂T0[ρ ]∂ρ (3.17)
with
V KS = Vext(r)+
∫
dr’ρ(r’)|r-r’| +Vxc[ρ ] (3.18)
where we have defined the exchange correlation potential
εxc(r) =
δExc[ρ ]
δρ (3.19)
Eq. 3.17 says that we can solve the original problem by finding the ground-state
energy for a system of non-interacting electrons in a effective potential. The single-
particle orbitals describing these electrons solve the self-consistent KS equations:
[1
2
∇2 +VKS(r)
]
ϕKSi = εiϕKSi i = 1, ...,N (3.20)
The total energy of the system is not the sum of KS eigenvalues, but can be
expressed as
E =
N
∑
i=1
εi− 12
∫
drdr′ρ(r)ρ(r’)|r-r′| + Exc[ρ ]−
∫
drVxc(r) ρ(r) (3.21)
With this method, the starting complexity of the problem is transferred to the
problem of finding a suitable formulation of the exchange-correlation functional,
which needs the introduction of other approximations.
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3.3 Exchange-Correlation functionals
3.3.1 Local density approximation (LDA)
In this approximation, already proposed in the seminal paper of Kohn and Sham
[99], and already introduced in the Thomas-Fermi-Dirac theory, the general in-
homogeneous electronic system is assumed to be a locally homogeneous electron
gas.
εLDAxc [ρ ] = εhomxc (ρ(r)) (3.22)
In that way, the otherwise non-local exchange-correlation functional becomes
dependent on r, i.e. local. By separating the two contributions to the Exc, the
exchange energy is exactly given by Dirac’s expression:
εLDAx [ρ ] =−
3
4
( 3
pi
) 1
3 ρ 13 (r) (3.23)
Many good approximations for the correlation term are available, some of
which solve analytically the problem in the high and low density limit [100, 101].
The most accurate results are given by quantum Monte Carlo simulations [102],
which has been parameterized in the folowing ref. [103]. Suitable (approximate)
analytical formulas have been derived by Vosko et al. (VWN correlation functional
[104]) and by Perdew and Wang (PW) [105].
It is not within the aim of this thesis to outline good and bad aspects of LDA
functional, but it is essential to mention that this functional is applicable to sys-
tems with slowly-varying densities, but cannot be formally justified for hughly
inhomogeneous systems, such as to and molecules, anf therefore exhibits heavy
deficiencies in describing biologically relevant systems [106, 107].
3.3.2 Gradient-Corrected approximations (GGA)
The progressive introduction of inhomogeneities in the electronic density could be
done using an expansion of the density in terms of its gradient, and higher order
derivatives. In general:
EXC[ρ ] =
∫
ρ(r)εXC[ρ(r)]FXC[ρ(r,∇ρ(r,∇2ρ(r), ...)]dr (3.24)
With the inclusion of these corrections GGAs functionals have been shown to
give good results for all the main bond types (ionic, covalent, metallic and hydro-
gen bonds) [108], but still, as for LDA functionals, vdW interactions are poorly
described [109].
One of the most popular GGA functional used in biochemistry is BLYP, which
is derived from the combination of Becke’s exchange functional B88 [110] and the
correlation functional of Lee, Yang and Parr (LYP) [111].
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3.3.3 Becke exchange functional
In this exchange functional the parameters were fitted to experimental molecular
data, and the functional was formulated in a way to reproduce the exact asymptotic
behavior of the exchange energy:
εx = ε
LDA
x
(
1− β
21/3Ax
x2
1+ 6βxsinh−1(x)
) (3.25)
and
x = 21/3
|∇ρ(r)|
ρ(r)1/3 , (3.26)
x gives a measure of the inhomogeneity of the system, and the parameter β =
0.0042 was obtained by a fit on known Hartree-Fock (HF) data for rare gas.
3.3.4 Lee Yang Parr correlation functional: LYP
The Lee-Yang-Parr (LYP) functional for the correlation energy was derived from
the Colle-Salvetti formula [111], and computes correlation energies from HF sec-
ond order density matrices. Its expression reads:
Ec[ρ ] =−a
∫ 1
1+ dρ−1/3 ρ + bρ
−2/3[CFρ5/3−2tW +(19tW +
1
18
∇2ρ)]e−cρ−1/3dr
(3.27)
where CF = 310(3pi
2)
2
3 , tW = 18
|∇ρ|2
ρ − 18∇2ρ . a=0.04918, b=0.132, c=2533 and
d=0.349 parameters are obtained by fitting the functional formula into HF results
for the Helium atom.
3.3.5 Plane wave basis set
Following the Bloch’s theorem [112] for periodic systems, a one-particle wave-
function can be written as Fourier’s series:
ϕk(r) = 1√
V
eik·r ∑
g
ckj (g)eig·r (3.28)
where V is the volume of the cell, k vectors belong to the first Brillouin zone,
g is a reciprocal lattice vector, c is the first Fourier component of the plane-waves
expansion, and the summation is extended to infinite lattice vectors. In the treat-
ment of isolated clusters with a low symmetry, such as, organic molecules or the
active sites of enzymes, the Γ-point approximation (k=0) still guarantees a good
accuracy, leading to a relevant reduction of the computational cost. The simulation
of isolated clusters within periodic boundary conditions scheme needs some care,
as self-interactions among replicas has to be canceled. In our calculations, we have
used the procedure developed by Martyna and Tuckerman [113], which links the
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expression of the electrostatic potential energy of a cluster to that of a infinitely
periodic system, allowing thus to take advantage of the Ewald method (see 3.7.2)
for isolated systems treated with a plane-wave orbital expansion. The algorithm is
based on the assumption that the electrostatic potential Φ can be written as the sum
of a short and long-range contributions:
Φ(r) = φ long(r)+ φ short(r) (3.29)
In a plane-wave expansion, the potential energy due to Φ can be expressed as
U = 1
2V ∑g |ρ¯(g)|
2
¯Φ(−g) = 1
2V ∑g |ρ¯(g)|
2[ ¯φ short(−g)+ ¯φ long(−g)] (3.30)
where ρ¯(g) and ¯Φ(−g) are the finite Fourier series of the density and the po-
tential, respectively, the finite Fourier series of f (r) being:
¯f (r) =
∫
V
dre−ig·r f (r) (3.31)
Requiring φ short(r) to vanish exponentially quickly at large distances from the
center of the cluster (d ∼ 2ds, where ds is the typical system size), we can express
this function as a Fourier transform plus an (exponentially vanishing) error term:
¯φ short(g) = ∫V dre−ig·rφ short(r) (3.32)
=
∫
all space dre−ig·rφ short(r)+ ε(g) (3.33)
= ˜φ short(g)+ ε(g) (3.34)
where ˜φ short(g) is the Fourier transform of φ short(r). Thus, neglecting the error
term:
¯φ(g) = ˜φ short(g)+ ¯φ long(g) (3.35)
= ˜φ short(g)+ ¯φ long(g)+ ˜φ long(g)− ˜φ long(g) (3.36)
= ˜φ (g)+ ˜φ screen(g) (3.37)
The function
˜φ screen(g) = ¯φ long(g)− ˜φ long(g) (3.38)
screens the interaction of the cluster with an infinite array of periodic images,
realizing the link between isolated and replicated systems (its value is zero in this
latter case). Thus, the potential energy can be written as:
U =
1
2V ∑g |ρ¯(g)|
2[ ˜Φ(−g)+ ˜φ screen(−g)] (3.39)
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In this expression ˜φ long(g) is supposed to be known, while ¯φ long(g) can be
evaluated efficiently over a grid using Fast Fourier Transform [114], which scales
as O (N lnN).
3.4 Pseudopotentials.
The greatest drawback in using a plane-wave basis-set comes from the impossi-
bility, from a practical point of view, of describing core electrons within a reason-
able computational expense. Indeed, the sharp spatial oscillations of their wave-
functions near to the nuclei would require an extremely high number of plane-
waves for an accurate characterization. On the other hand, the core levels are
well separated in energy from valence electrons and, at a first level of approx-
imation, do not play any role in the chemical properties of molecular systems.
Thus, the core electron orbitals can be frozen in the KS equations and only the
valence electrons are described explicitly. The core-valence electron interactions
are implicitly included into the nuclear potential, which becomes an ’effective-
potential’ or ’pseudopotential’. Pseudopotentials are usually derived from all elec-
tron (AE) atomic calculations, and several recipes have been proposed to date. In
the work presented in this thesis ”norm-conserving” pseudopotentials derived from
the Martins-Troullier (MT) method [115] have been used. These pseudopotentials
have to satisfy the following conditions:
• The valence pseudo-wave-function should not contain any radial nodes.
• The valence AE and pseudopotential eigenvalues from the radial KS equa-
tions must be the same:
εPPℓ = ε
AE
ℓ (3.40)
where ℓ is the angular momentum.
• The pseudo and AE atomic radial wave-functions must be equal for r greater
than a chosen cut-off distance rcut .
These three conditions ensure that the pseudo-atom behaves like the real one
in the region of interaction with other atoms while forming chemical bonds. Other
conditions are the following:
• The integrated electron density within the cut-off radius for the two wave-
functions must be the same. This requirement guarantees the transferability
and the norm conserving rule of the MT pseudopotential.
• At r = rcut , the pseudo wave-function and its first four derivatives should be
continuous.
• The pseudopotentials should have zero curvature at the origin.
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With these conditions, the general form for a pseudopotential wave-function is:
ϕPPℓ (r) =
{
ϕAEℓ (r) ; r > rcut
rℓep(r); r ≤ rcut (3.41)
where p(r) = c0 +∑6i=1 cir2i, and the coefficients are obtained by imposing the
first three conditions.
The functional form of the pseudopotential is
Vpseudo = Vval(r)+∑
m,l
|Yl,m〉Vl(r)〈Yl,m| (3.42)
where |Yl,m〉 are spherical harmonics. The ”semilocality” of this functional
form (local in the radial coordinate, non local in the angular ones), implies an
increase in the computational cost. This difficulty can be overcome by using the
method of Kleinman-Bylander [116], which implies addition and subtraction of an
”ad-hoc” radial function VL(r) to the pseudopotential, leading to a new functional
form, where the local and non-local parts can be completely separated.
3.5 Car-Parrinello MD
Now that we have presented the method used in this work, to solve 3.6, with the
help of suitable approximations, we face the prolem of how to solve the time-
dependent Schro¨edinger equation, because we are interested in simulating the time
evolution of biological systems (namely enzyme in this work) which undergo bonds
breaking and formation: that requires a first principle approach.
Recalling 3.7, one can write the time-dependent adiabatic Schro¨edinger equa-
tion for the nuclear wave-function
ih¯∂Θm(R, t)∂ t =
(
−
P
∑
I=1
h¯2
2MI
∇2I + ε(R)
)
Θm(R, t), (3.43)
with
εn(R) = εon (R)+
P
∑
I=1
h¯2
2MI
〈Ψq|∇2I |Ψq〉, (3.44)
which represents the diagonal correction to the electronic energy levels, due to
the dependence of the electronic wave function on the nuclear coordinates 1
Using Ehrenfest’s theorem, mean values of position and momentum operator
could be obtained:
ih¯ d〈R〉dt = 〈[
ˆH ,R]〉= ih¯ P
M
(3.45)
1This correction is proportional to m/M, and therefore feasible: when explicitly neglected, it
receives the name of Born Oppenheimer approximation, when included one speaks of adiabatic
approximation.
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and
ih¯ d〈P〉dt = 〈[
ˆH ,P]〉=−ih¯〈∇εn(R)〉, (3.46)
which combined give rise to the following Newtonian equation of motion:
M
d2〈R〉
dt2 =−〈∇ε(R)〉. (3.47)
Using Hellmann-Feynman theorem [117, 118], it could be possible to write the
second term in 3.47, in the classical nuclei approximation (which means assuming
to have obtained the mean value of the position operator in some way):
MI
d2RI(t)
dt2 =−
〈
Ψn(R)
∣∣∣∂he(R)∂RI
∣∣∣Ψn(R)〉− Vnn(R)∂RI , (3.48)
where Vnn is the nuclear-nuclear interaction.
A first principle self-consistent MD approach can be obtained by solving the
electronic structure problem for the ground-state (for example within the Khon-
Sham approach to DFT).
In this way one can obtain the electronic ground-state for each MD steps, but
this requires diagonalization of the electronic Hamiltonian at each step, which takes
a lot of computational time.
3.5.1 the Car-Parrinello Lagrangian
In 1985 Car and Parrinello developed a new scheme, based on the extended La-
grangian formalism and avoiding the optimization of the electronic wave function
of every step by introducing a second order fictitious dynamics on the electrons.
These latter are kept sufficiently close to the adiabatic surface, allowing for an in-
crease of the time step by a factor ∼ 10 with respect to Ehrenfest dynamics. The
method is based on the observation that 〈Ψ0|H |Ψ0〉 can be viewed not only as a
function of {RI}, but also as a functional of the wave function Ψ0, and thus of the
set of one-electron orbitals {ψi} used to build it. In this case, the force acting on
these orbitals can be obtained from a functional derivative of a suitable Lagrangian
containing 〈Ψ0|H |Ψ0〉, like in classical mechanics for the nuclear motion. The
Lagrangian L proposed by Car and Parrinello has the form
L =
M
∑
i=1
1
2
MI ˙R2I +
N
∑
i=1
1
2
µi
〈
ψ˙i
∣∣∣ψ˙i〉−〈Ψ0|He|Ψ0〉+ constraints (3.49)
where the first term is the kinetic energy of nuclei, and µi = µ are the ”fictitious
masses” assigned to orbitals; the second term represents the fictitious kinetic en-
ergy associated to them (the sum is on the occupied orbital only). The (holonomic)
constraints act in general on both the orbitals (e.g. to guarantee orthonormality)
and on the nuclei (e.g. if one would perform molecular dynamics with geometric
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restraints). The dynamics is described by the Euler-Lagrange equations associated
to L
d
dt
∂L
∂ ˙RI
= MI ¨RI =
∂L
∂RI
=− ∂∂RI 〈Ψ0|He|Ψ0〉+
∂
∂RI
{constraints} (3.50)
d
dt
∂L
∂ψ˙∗i
= µiψ∗i =
∂L
∂ψ∗i
=− ∂∂ψ∗i
〈Ψ0|He|Ψ0〉+ ∂∂ψ∗i
{constraints} (3.51)
Note that if |µψ¨i| → 0 eq. 3.51 reduces to a stationary problem, and the elec-
tronic system will stay on the Born-Oppenheimer surface (no forces acting on or-
bitals), corresponding to the true equilibrium dynamics. Higher is the fictitious
kinetic energy Te = ∑Ni=1 12 µi
〈
ψ˙i
∣∣∣ψ˙i〉, more the electrons will be far from the min-
imum energy configuration. In particular, a ground-state wave function optimized
at time t0 will stay close to its ground-state if it is kept at sufficiently low tempera-
ture. The only quantity one can change to ensure this condition is µ , often called
”adiabaticity parameter” [119]. If µ and τ are chosen consistently the energy flow
between electronic and nuclear subsystems is slow enough to cause no drift in Te 2,
thus conserving the ”physical” total energy Ephys:
Ephys = Etot −Te = TI +Ve =
M
∑
i=1
1
2
MI ˙R2I + 〈Ψ0|He|Ψ0〉 (3.52)
The choice of a reasonable fictitious mass µ meets two opposite requirements.
In fact, considering a simple harmonic model for the electronic system around the
Born Oppenheimer (BO) surface, (discrete) excitations frequencies are given by
ωei j =
√
2(ε∗i − ε j)
µ (3.53)
where ε∗ and ε are energy levels of unoccupied and occupied orbitals, respec-
tively. If ωnmax is the maximum vibrational frequency of the nuclear system, in
order to perform adiabatic dynamics it must be ωegap >> ωnmax. As the only tunable
parameter is µ , one could decrease it arbitrarily to increase the frequency of the gap
ωemin. However, decreasing µ stretches the entire spectrum {ωei j} and in particular
increases ωemax, which is inversely proportional to the maximum time step. Typical
values of µ are in the range 500− 1500a.u., which allow for a time step of about
5− 10a.u. (0.12− 0.24fs). For calculations discussed here we used µ = 600a.u.
and a time step of 5a.u.
2 Te actually performs two-frequency bound oscillations around a constant value. The first fre-
quency is associated to the drag exerted by the nuclei, and it is in anti-phase with Ve oscillations,
while the second is a small-amplitude high-frequency oscillation intrinsic to the fictitious electronic
dynamics. Note that having a non vanishing masses, also the electrons dampen nuclear motion,
causing a renormalization of the nuclear masses which can be important in the case of light atoms.
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3.6 Hybrid Models: QM/MM molecular dynamics
The biological systems like those addressed in this study, namely enzyme in action,
require special computational techniques. They are proteins, usually composed by
a thousands of atoms, and they perform chemical reactions, which happen in a
limited part of the enzyme, called active site (usually smaller than a hundred of
atoms). Treating the whole system quantum mechanically, by using first principle
approaches, is computationally not-affordablei. In addition this may not necessarly
cause one is interested only in the catalytic region (a hundred of atoms). The ap-
proximation of the enzyme to only a models of its catalytic site in vacuo is rather
drastic, and one looses electrostatic contributions of the whole system and a cor-
rect description of the internal motions of the protein, which are crucial for a full
description of the catalytic mechanism. For that issue, hybrid models which allow
to treat different parts of the system at different level of theory were developed
[120, 121, 122, 123]. According to these approaches, the Hamiltonian for a hybrid
system could be written as:
H = HQM + HMM + HQM/MM (3.54)
where HQM and HMM are the Hamiltonian for the quantum and classical sys-
tems respectively, and the remaining term HQM/MM , which incorporates the essence
of hybrid methods, describes the interactions between the two subsystems.
In this work we have benefit the use of the hybrid method developed by U.
Roethlisberger and co-workers [123], in which the QM part is treated at DFT/BLYP
level of theory (as described in 3.2) and dynamics is performed following Car-
Parrinello idea, whereas classical part is described using AMBER force-field [124].
An important issue when using hybrid methods, is the way in which the quan-
tum and the classical subsystems are divided: it is possible to group degrees of
freedom as bonded and non-bonded interactions, dependently on how the QM/MM
boundary cuts or not chemical bonds of molecule.
3.6.1 Bonded interactions
The first problem that one has to face when a QM atom is chemically bonded to a
MM one, is the remaining unsaturated valence of the terminal QM atom. Among
the possible proposed solutions [125, 126, 127, 128, 129]: here we have simply
added an additional (dummy) hydrogen atom to saturate the dangling bond.
Stretch, angle and dihedral interactions involving MM and QM atoms are kept
in account by the classical MM force field used.
3.6.2 Non-bonded interactions
The natural choice for the non bonded interaction Hamiltonian is:
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Hnon−bonded = ∑
i∈MM
qi
∫
dr ρ(r)|r− ri| + ∑i∈MM ∑j∈QM vvdW (ri j), (3.55)
The steric non-bonded interactions due to the Pauli repulsion and the dispersion
interactions are kept into account by retaining the van der Waals interaction as
described by the MM force field.
The electrostatic interaction between the QM density and the point MM charges
representing the main environmental effect on the QM system, presents some is-
sues: (i) the electron spill-out phenomenon and (ii) a very high computational cost.
In the QM/MM scheme followed here [123], these problems are overcome by
treating in a different way short and long range interactions.
3.6.3 Short-range electrostatic interactions
The so-called electron spill-out problem is a consequence of the non-physical at-
traction of the electron cloud, caused by positive MM charges, located near the
QM/MM boundary. These positive charges are not surrounded by its own elec-
tron density, and the Pauli repulsion is therefore absent: as a consequence the QM
electron density is over polarized.
This effect is particularly pronounced in a PW basis set approach, in which the
electrons are fully free to de-localize.
In the solution proposed in [123], the Coulomb potential is replaced by
Hel = ∑
j∈MM
q j
∫
drρ(r)
r4c j − r4
r5c j − r5
, (3.56)
where rc j is the covalent radius of the atom j. In that way, for large r value,
the 1/r behavior of the Coulomb potential is still present, while it tends to finite
number for small r.
This choice of the smoothing function has been tested to produce accurate re-
sults for the structural properties of a quantum water molecule in a box of classical
water molecules without any ad hoc re-parametrization of the force field, and an
accurate description of hydrogen bond distances and energetics can be obtained.
3.6.4 Long-range electrostatic interaction
The explicit calculation of the long-range electrostatic term is too expensive in a
plane-wave based approach. In fact, the calculation of about Nr·NMM integrals,
where Nr is the number of real-space grid points (≈ 103) and NMM is the number
of classical atoms (≈ 105) would be required. This problem is solved by lowering
the degree of accuracy of the calculation as the MM atoms get further from the QM
region. The MM region is partitioned into three regions by providing two cut-off
radii r1 and r2.
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• Interaction of the QM charge distribution with all MM atoms within r1 is
explicitly calculated.
• For MM atoms with r1 < r < r2, the Coulomb interaction is approximated to
interaction between the MM atomic point charges and the D-RESP charges
[130] of the QM system (see below for D-RESP charges derivation). Thus,
the electrostatic Hamiltonian reads:
H
el
QM/MM =
r1≤r≤r2∑
i, j
qiQRESPj
|Ri−R j| (3.57)
• for r > r2 The MM charges interact with a multi-polar expansion (up to the
quadrupolar term) of the QM charge distribution. In this case, the Hamilto-
nian takes the form:
H
el
QM/MM = C∑qi 1|r−Ri| +∑α D
α ∑qi (R
α
i − r¯α)
|r−Ri|3 +
+
1
2 ∑
αβ
Qαβ ∑qi (R
α
i − r¯α)(Rβi − r¯β )
|r−Ri|5 + ... (3.58)
where r¯ is the origin of the multi-polar expansion (e.g., the geometrical cen-
ter of the quantum system) and C,D and Q are the total charge, the dipole
and the quadrupole quantum charge distributions, respectively.
The only free parameters in this approach are the cut-off radii r1 and r2. This
approach allows a fully Hamiltonian description of the electrostatic interactions.
Thus, energy conservation during dynamics is achieved if the potential energy and
the forces are consistently computed. The correctness of the implementation can
be directly verified by monitoring the conservation of the energy during MD simu-
lations.
3.7 Classical molecular dynamics
All the techniques described above, albeit accurate, are computationally expensive
and allow to treat relatively small problems. More than this, not all the questions
addressed in computational biophysics involve bond breaking or formation (for
example one could be interested in study the large scale motion of a protein, or
movement of some particular domain). For all these cases, an accurate description
as obtained by ab-initio calculations is out of scope, and sometime even a waste
of computational resources. In the so called force field methods, the electronic
energy for a given nuclear configuration is not calculated solving the Schro¨edinger
equation, using some approximate methods, but it is given as a parametric function
of nuclear coordinates, which are fitted to experimental values, or higher level
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computational data. In this framework electrons are not explicitely considered,
and the problem becomes a classical one: the equation of motion are therefore
obtained using a standard Hamiltonian (or Lagrangian) formalism, and trajectories
are obtained solving these equations of motion using some ad hoc algorithm [131].
In this work we have used not only in the classical MD calculations, but in
mixed QM/MM as well, the AMBER force field [132], whose functional analytical
form is:
U = ∑bonds Kr(r− req)2 + ∑angles Kϑ (ϑ −ϑeq)2 + (3.59)
+∑dihedrals Vn2 [1+ cos(nφ − γ)]+ ∑i< j[4εi j(σi jri j )12− (
σi j
ri j )
6 +
qiq j
εri j ]
Atom bond stretching and angle bending are represented as harmonic terms,
while dihedrals or torsionals are described by a sinusoidal term. Non-bonded inter-
actions comprise two terms, the first is a Lennard-Jones (LJ) 6-12 which describes
atom-atom repulsion and dispersion interactions, the second is the Coulomb elec-
trostatic term. In eq. 3.59, r and ϑ are respectively the bond length and valence
angle; φ is the dihedral or torsion angle and ri j is the distance between atoms i and
j. Parameters include the bond force constant and equilibrium distance, Kr and req,
respectively; the valence angle force constant and equilibrium angle, Kϑ , and ϑeq,
respectively; the dihedral force constant, multiplicity and phase angle, Vn, n, and
γ , respectively. Non-bonded parameters between atoms i and j include the partial
atomic charges, qi, along with the LJ well-depth, εi j, and σi j, the (finite) distance
at which the inter–particle potential is zero. These terms are also referred to as
the interaction or external parameters. Typically, εii and σii are obtained for indi-
vidual atom types and then combined to yield εi j and σi j for the interacting atoms
via combining rules. The dielectric constant ε is typically set to 1 (correspond-
ing to the permittivity of vacuum) in calculations that incorporate explicit solvent
representations [133]. Van der Waals and electrostatic interactions are calculated
between atoms belonging to different molecules or for atoms in the same molecules
separated by at least three bonds.
3.7.1 Long-range interactions in classical MD
In simulations of biological systems it is highly desirable to avoid the calculation
of all non-bonded pair interactions, since the computational cost would be propor-
tional to the square of the number of atoms. These interactions primarily dictates
the dynamics of biomolecules, and cannot be merely truncated beyond a given cut-
off [131] when long-ranged. An interaction can be roughly defined long-range if
the associated energy falls off slower than r−d , where d is the dimensionality of the
system. Thus, Coulomb (∼ φ−1) and dipole-dipole (∼ φ−3) should be considered
long-range when dealing with three dimensional systems. Indeed, cutting the in-
teraction on a sphere of radius rc makes it is easy to see that the tail correction, pro-
portional to
∫
∞
rc
φ(r)4pir2 diverges if the potential function goes to zero with r→∞
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faster than r−3. 3 Fortunately efficient methods to handle the evaluation of long-
range interactions were developed. Among these, the most used are reaction field
methods and lattice methods [134]. The first class assumes that beyond a given dis-
tance the interaction can be treated using an “average field” approach, derived from
macroscopic electrostatic. The second class of methods, much more widely used,
is represented by the Ewald summation algorithm [135], which efficiently handles
long-range interactions in periodic systems (and thus requires Periodic Boundary
Conditions - PBC - to be used for the system being simulated).
3.7.2 Ewald sum
Within PBC each particle interacts with all the other N-1 particles into the simula-
tion box and with all the N particle images in an infinite 3D array of periodic cells.
The electrostatic potential energy UCoul of the infinite system, therefore, takes the
form:
UCoul = 1
2 ∑n=0
′
N
∑
i j
qiq j
|rij + nL| (3.60)
where L is the length of the periodic box (assumed cubic for simplicity), N
is the total number of atoms, and n are the direct lattice vectors. The prime on
the summation indicates that the sum is over all the images n, and i 6= j if n = 0.
The convergence of this series is extremely slow, and thus a very large number
of images is required to achieve a reliable estimate of UCoul . A simple recipe to
cope with this problem consists in splitting the electrostatic energy in two parts, a
short-range and a long-range term. This means to find some function β such that
the Coulomb potential can be rewritten (x≡ |rij + nL|):
1
x
=
β (x)
x
+
1−β (x)
x
(3.61)
If β is properly chosen, the first term will be negligible beyond a given cutoff
xc, and the latter will be a slowly varying function of x, that can be expressed as
Fourier Series with a low number of k points. Ewald [135] made for β (x) the natu-
ral choice of the complementary error function erfc(x)= (2/
√
(pi))
∫
∞
x exp(−u2)du,
such that 1−β (x) = 1−erfc(x) = erf(x). Thus, in eq. 3.61 the term erfc(x) is evalu-
ated cutting the interactions at a given cut-off, while the long-range term is Fourier
transformed in the reciprocal space, where it becomes short-ranged and can be
thus accurately estimated by summing over a limited number of reciprocal vectors
(both the sums in real and reciprocal space becomes in fact exponentially con-
verging). The parameter α tunes the relative weights of real and reciprocal sums,
although the final result is independent of it. An optimal choice makes the Ewald
3 The LJ interactions, instead, can be cut at a given cutoff (typically 10-12 A˚), since they decay
very rapidly. Methods have been developed that treat the region beyond the cutoff radius rc as being
homogeneous (i.e. with LJ parameters averaged over all the LJ atom types) [131]. These interactions
are thus effectively treated as short-range interaction, with the addition of a constant correction term.
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sum to converge as N3/2, which can be further improved to N lnN with the use of
Particle-Mesh methods (as the Particle-Mesh Ewald, PME [136] or the Particle-
Particle Particle-Mesh, PPPM [137]), making advantage of the Fast Fourier Trans-
form (FFT) [114] algorithm.
3.8 Performing MD in a statistical ensemble
Solving the equation of motion presented above, independently on the level of
theory used (classical MD or ab initio), will generate trajectories which map a
micro-canonical ensemble4, as the total energy is strictly conserved during time
evolution. Experiments on the systems I have addressed here (catalytic enzymes),
but generally for every biophysical experiments, are performed at constant pres-
sure and temperature (NPT ensemble), or constant volume and temperature (NVT
ensemble). This means that, from the statistical mechanics point of view, it is
necessary to use special techniques which allow one to sample statistical relevant
canonical ensembles.
3.8.1 Nose´ thermostat
A way to achieve constant temperature simulations, within the framework of MD,
was introduced about twenty years ago by Nose´ [138] and reformulated by Hoover
[139], who modify Newton equation of motion by adding two non physical vari-
ables, thus introducing the following non-Hamiltonian dynamical system:
r˙i =
pi
mi
, (3.62)
p˙i = Fi− pηQ pi , (3.63)
η˙ = pηQ , (3.64)
p˙η =
N
∑
i=1
pi2
mi
−LkT . (3.65)
where {ri},{pi} are coordinates and momenta of the N particles with masses mi,
the forces Fi are derived from the N-particle potential and L is a parameter to be
determined. The two nonphysical variables η and pη in eq. 3.62 regulate the
fluctuations in the total kinetic energy of the physical variables, and can be thus
regarded as an effective ”thermostat” for the physical system. The parameter Q
controls the strength of the coupling to the thermostat: high values result into a
low coupling and vice versa. These equations of motion conserve the following
quantity:
C = H(p,r)+
p2η
2Q + LkTη (3.66)
4assuming that ergodic hypotheses are verified
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where H(p,r) is the physical Hamiltonian. Assuming that C is the only constant of
motion, the microcanonical partition function at temperature T can be written as:
ΩT (N,V,C) =
∫
dNpdNrd pη dη e3Nη δ (H(p,r)+ p
2
η
2Q + LkTη −C) (3.67)
= e
3NC/LkT
LkT
∫
d pη e−3N p
2
η/2QLkT ∫ dNpdNre−3NH(p,r)/LkT (3.68)
that, with L = 3N, is proportional to the canonical partition function for the physical
system. Thus, the Nose´ “extended” scheme gives conformations of the physical
systems that belong to the canonical ensemble. In eq. 3.67, the metric e3Nη has
been used as dNpdNrd pη dη e3Nη is the phase-space conserved measure for this
set of equation of motion.
Nose´-Hoover chains
When there is more than one constant of motion a single Nose´-Hoover thermostat
is unable to get the correct canonical sampling for the physical system [131]. To al-
low the simulation of more general systems Martyna et al. [140] devised a scheme
in which additional dynamical variables are inserted in the Lagrangian. This cor-
responds to couple the first thermostat to another one, and so on, generating a
whole chain of thermostats (here the name Nose´-Hoover chains). In fact, as the
momentum of the extended variable entering in the first Nose´-Hoover thermostat
is distributed canonically, it can also be thermostated. The chains take into account
for additional conservation laws, and generates the correct canonical distribution.
The equations of motion for a system coupled to Nc thermostats are:
r˙i =
p˙i
mi
, (3.69)
p˙i = Fi− pη1Q1 pi , (3.70)
η˙k =
pηk
Qk , k = 1, ...,Nc, (3.71)
p˙η1 = (
N
∑
i=1
p2i
mi
−LkT)− pη2Q2 pη1 , (3.72)
p˙ηk = (
p2ηk−1
Qk−1 − kT)−
pηk+1
Qk+1 pηk , (3.73)
p˙ηNc = (
p2ηNc−1
QNc−1
− kT) . (3.74)
The dynamics generated by these equations conserves the following ”energy”:
HNHC = H(p,r)+
Nc∑
k=1
p2ηk
2Qk + LkTη1 +
Nc∑
k=2
kT ηk (3.75)
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3.8.2 Isobaric simulations: Langevin piston
As for the thermostat many methods [134] have been developed for the aim of
performing simulations at constant pressure. Here will be presented only the one
used in this work (in classical MD performed using the NAMD code [141]). The
equation of motion of each atom are modified by the introduction of an additional
degree of freedom, the piston σ , which undergoes a Langevin-like dynamics, in
analogy with the motion of each particle
r˙i =
pi
mi
+ 13
˙V
V ri, (3.76)
p˙i = fi− 13
˙V
V p, (3.77)
¨V = 1W [P(t)−Pext ]− γ ˙V + R(t), (3.78)
(3.79)
where γ is the collision frequency and R(t) is a random force taken from a
Gaussian distribution with zero mean and variance
〈R(0)R(t)〉= 2γkbT δ (t)
W
(3.80)
where kb is Boltzmann’s constant.
3.9 Free energy calculations
The biochemical events addressed with computational approaches usually involve
the crossing of relatively high energy barriers: in particular, one aim of this work
is the characterization of enzymatic reaction, for which we have experimentally
measured quantities (kcat ) of the order of tenths of kcal/mol.
The time required for crossing such high energy barriers is not accessible with a
normal, canonical, molecular dynamics simulations, and methods for enhanincing
the sampling of the free energy surface (or the phase-space) are necessary. For that,
a number of powerful methods have been developed, in recent years, to characterize
the thermodynamics of many rare events [142, 143, 144, 145, 146, 147, 148, 149,
150, 151].
Forcing the system to undergo the requested transformation, and then recon-
stracting the free energy profile, implies two major problems: (i) the simplification
of the phase space into few (or even only one) relevant paramenters, called reac-
tion coordinates, along which to enforce the transformation, and (ii) to achieve the
definition of efficient schemes for sampling the reduced phase space.
In principle reduction of the complexity and intrinsic multidimensionalty of a
system to the few reaction coordinates could seem a rather drastic simplification,
but for some case (in particular for some enzymatic reactions), the low-dimensional
approximations are reasonable. In particular in this work, the hydrolysis reaction
performed by the enzyme are approximated using a monodimensional reaction co-
ordinate, and profile of (Helmotz) free energy are here briefly presented.
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3.9.1 Constraint MD
The Constraint MD method has been developed by Ciccotti et al. [152, 153] and
has been used to a variety of molecular systems up to date.
In this scheme, the reaction free energy is calculated by rigidly constraining the
chosen reaction coordinate. The force on the constraint (f) is time-averaged upon
successive variations of the reaction coordinate value R, and then integrated along
R. The free energy, then, reads:
∆G(R) =
∫
R
R0
¯f(R ′)dR ′ (3.81)
For the simple case of an interatomic constraint, like in the case of the sim-
ulations of this work, the force on the constraint is equal to the corresponding
Lagrange multiplier:
¯f(R) = 〈λ (R)〉 =−
〈 ∂V
∂RAB
− 2kBT
RAB
〉
RAB=R
(3.82)
where the brackets stand for an ensemble average over the trajectory, and the
reaction coordinate R is defined by the distance between atoms A and B.
The validity of this thermodynamic integration scheme is independent on the
nature of the interatomic forces, and it has been successfully extended to a variety
of chemical systems. Practically, the value of R is increased or shortened in a
small amount starting from the final configuration of the simulation at the former
R value. The amount of these increments determines the accuracy of the free
energy estimation for e.g. a chemical transformation: nonetheless, the shorter they
are, the more time-consuming the simulation will be.
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Part II
Computational studies on B2
MβL CphA
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Chapter 4
Protonation state and substrate
binding of CphA
4.1 Summary
The zinc enzymes metallo β -lactamase counteract the beneficial action of β -lactam
antibiotics against bacterial infections. These enzymes hydrolyze the β -lactam
ring. To understand structure/function relationships on a representative member
of this class, the B2 MβL CphA, we have investigated the H-bond pattern at the
Zn site and substrate binding mode by molecular simulation methods. Extensive
QM calculations at the DFT-BLYP level on 11 models of the protein active site,
along with MD simulations of the protein in aqueous solution, allow us to propose
two plausible protonation states for the unbound enzyme, which are probably in
equilibrium. Docking procedures along with MD simulations and QM calculations
suggest that in the complex between the enzyme and its substrate (biapenem), the
latter is stable in only one of the two protonation states, in addition it exhibits
two different binding modes, of which one agrees with previous proposals. In
both cases, the substrate is polarized as in aqueous solution. We conclude that
addressing mechanistic issues on this class of enzymes requires a careful procedure
to assign protonation states and substrate docking modes.
4.2 CphA in the free state.
We attempted to identify the most plausible protomers of B2 MβL active site by
evaluating the relative stability of different protomers representing the CphA active
site, optimized at the DFT-BLYP level of theory (Tab.4.1).
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Model His118 His196 4thligand RMSD (A˚) ∆E (kcal/mol)
A ε ε WAT 0.15 0
A2 δ δ WAT 0.29 15.15
A3 ε δ WAT 0.20 7.10
A4 ε δ WAT 0.37 1.70
B ε and δ ε OH 0.14 0.67
B2 δ δ OH 0.37 39.99
B3 ε ε OH 0.16 36.13
B4 ε δ OH 0.39 50.97
B5 ε δ OH 0.21 52.77
B6 ε ε OH 0.39 27.80
B7 ε and δ ε OH 0.25 2.38
Table 4.1: Different protomers used in the QM calculations. The first three
columns report the protonation of His118, His196 and the ligand that replaces
crystallographic carbonate anion [154]. Structure (RMSD) and relative energies
(∆E) of different protomers representing the CphA active site are reported in the
last two columns.
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The Zn(II) ion was assumed to be tetrahedral, based on the spectroscopic evi-
dence [155]. These models included: i) The metal and its protein ligands Asp120
(assumed to be ionized), Cys221 and His263; the latter binds Zn(II) on Nε and
reasonably H-bonds with Gln68, This residue was not included in models, since
its inclusion was expected not to significantly alter the results of calculations: H-
bond Gln68@CO... HNε@His263 would be present in all models considered, and
would stabilize them in the same extent. ii) Either a water molecule (Waz) or a
hydroxide ion (Oz) acting as fourth ligand; this ligand replaces the carbonate (or
bicarbonate) of the X-ray structure.
iii) The three residues of the ”Zn1” binding site: Asn116, His118 (protonated ei-
ther in Nδ , H-bonding to water Wat2, or in Nε , H-bonding to OH-Tyr117. This
residue was not included in calculation. According to the crystal structure [154],
Tyr117@HO...HNε@His118 is most likely to be present, compared to Tyr117@OH...Nε@His118
(putative HO...N angle of about 220o, Fig. SI): for that reason most of our models
were built with His118 protonated on Nε . Explicit inclusion of Tyr117 would be
more effective on stabilization of models with His protonated on Nε than on those
protonated on Nδ . Furthermore, A2 and B2, the only two models with His118
protonated on Nδ , turned out to be less stable compared to all other models. and
His196. The latter faces water in the crystal, and it was consequently assumed to
be protonated either in Nε (thus forming and H-bond with Waz or Oz,) or on Nδ ,
forming a H-bond with a third water molecule (Wat3); iv) Arg121 was included for
its positive charge, which is expected to play an important role in electrostatics of
the active site cavity [93, 94]. v) Two additional water molecules (Wat2 and Wat3),
which H-bond to His118 and Asp120, and to Asn116 and His196, respectively.
The most stable models in terms of energetic and structural properties (RMSD
relative to the X-ray structure) turned out to be A and B in which the fourth Zn
ligand is a water or a hydroxide group, respectively (Tab. 4.1 and in Fig. 4.1).
The energies of the two models differed by less than 1 kcal/mol and their struc-
tural parameters were fairly similar to those of the X-ray structure (RMSD= 0.14
A˚ for A and 0.13 A˚ for B); in particular, the Zn(II) ion exhibits a tetrahedral coor-
dination sphere. Two other models turned out to have low energy: A4 and B7 (Tab.
4.1).
Model A4 differs from model A only in the protonation of His196. We performed
short test MD simulation of this protomer observing that the χ1 and χ2 of His196
adjust, exposing the NδH group to the solvent, in a similar geometry as those of
His196 in model A. Therefore we decided to use the protonation state of A. Model
B7 features the same protonation state of B, differing only in an additional crystal-
lographic water molecule. (Tab. 4.1) We exclude all the other models considered
by using an energetic criterion and/or a structural one (Tab. 4.1). In A, His118 and
His196 are protonated in Nε (Fig. 4.1): Wat2 is involved in a network of H-bonds
with Oδ2@Asp120, Nδ@His118 as acceptors, and one hydrogen of Waz as donor.
In B His118 is diprotonated, and Wat2 forms a H-bond network with O@Oz and
Oδ2@Asp120 as acceptors, and NδH@His118 as donor (Fig. 4.1). In both models
Wat3 is H-bonded to the Nδ of His196 and the amide group of Asn116. Overall,
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a comparison between these two models indicates that the difference is a relayed
proton transfer between the metal bound Waz and His118. Thus, both protomers
could coexist, being almost isoenergetic and they could be also in equilibrium with
each other.
The stability of the protein in the protonation states A and B was then investi-
gated by MD simulations of the entire proteins in aqueous solutions. The overall
folds were well conserved for 10 ns, as shown by RMSD value of the backbone
(MD-averaged value 1.1 A˚, Fig. 4.2).
The RMSF calculated over Cα atoms
(Fig. 4.3a) pointed to a mobility of regions L1, helixα3/L5 and L9, located near
the edge of active site: these values are in good agreement with the experimental
B-factors [154], except for L1, which has low experimental values.
The geometrical parameters of the Zn(II) site were preserved during the dy-
namics in both models. In the CphA-A model a second water molecule was ap-
proaching the metal site with an exchange time of about 0.3 ns. The H-bonds be-
tween NεH@His118 and O@Tyr117, NH@His118 and Oδ@Asn116, and His263
Nδ and Gln68 as well as the Cys221-Arg121 salt bridge, were well conserved in
both models.
Novel information is obtained on the structural role of Lys224, which in the
X-ray structure was involved in a salt bridge with the exogenous carbonate anion.
During the dynamics, it is H-bonded to Tyr297, Tyr242, Leu232 and His196 Nδ
(Fig. 4.2). The structure of this H-bond network prevents the terminal positive
charge of the Lys residue to be solvent exposed. In summary, our calculations
pointed out that both CphA-A and CphA-B protomers may be present in resting-
state of CphA.
Figure 4.1: Active site protomers of CphA emerging from our DFT-BLYP calcu-
lations. The 4th Zn ligand is a water molecule (Waz) in A, and an OH group (Oz)
in B.
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Figure 4.2: MD simulations of CphA in the free state. Top: the RMSD (A˚) of
CphA-A (red) and CphA-B (black).
Bottom: initial (red) and final (blue) representative structures from MD simulations
of CphA-A: in the absence of the carbonate anion, Lys224 forms salt bridges with
two tyrosines (Tyr242 and Tyr 297) and it is buried in the active site cavity. The
MD structure of CphA-B turned out to be very similar to CphA-A.
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Figure 4.3: Panel (a): calculated and experimental B-factors (blue) for CphA-A
(red) and CphA-B (black). Panel (b): the B-factors of CphA in complex with Bia
derivative [154] are compared with those of our stable MD complexes, namely
those of ES-1A(red) and ES-2A (black).
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Figure 4.4: ES-1A (a) and ES-2A (b) MD average structures. The putative water
molecules (Wat2) acting as nucleophile in the enzymatic reaction are highlighted
with circles; the second zinc coordinated water (Waz) is indicated with dashed
circle in (b).
4.3 CphA-Bia Michaelis complex.
In this section we investigate the stability of the complex between CphA and its
substrate (Bia) in both protonation states by performing MD simulations of the
adducts. Two docking models were considered for each protonation state of the
protein residues of the zinc environment. These models differ also for the Zn coor-
dination: in models ES-1 the Zn is bound to the substrate, whilst in models ES-2
a water molecule or an hydroxide are directly coordinated with the metal ion (Fig.
4.5). The latter is based on the hypothesis that B2 MβL use this moiety to per-
form the catalytic reaction, as found in all B1 MβLs (COOREGGI REFS). Specif-
ically: in models ES-1A and ES-1B the carboxylic moiety of Bia was coordinated
to the metal ion, as in the crystallographic structure of CphA in complex with a
Bia derivative [154], and with a salt bridge between Lys224 and O(12)@Bia. The
possible nucleophile was a water molecule or an hydroxide (Wat2 or OH-2) respec-
tively, placed in the pocket between His118 and Asp120. Instead, models ES-2A
and ES-2B were based on the protomers A and B in which Bia was docked into the
active site without assuming direct binding of the carboxylate moiety to the zinc
ion (Fig. 4.4, 4.5). In that model, Lys224 forms a salt bridge with O(13)@Bia.
After 10 ns of classical MD simulation of ES-1A and ES-2A the RMSD of the
final MD structures were close to those of the free states, ranging from 0.9 A˚ to 1.1
A˚ (± 0.1 A˚). The enzyme folds were fully maintained along the dynamics and the
structure of Bia was well conserved (RMSD 0.15 A˚± 0.01 A˚). Wat2 formed stable
hydrogen bonds with Nδ@His118 and with Oδ1@Asp120. In model ES-2A Waz
acted always as fourth ligand to the metal ion, H-bonding with carboxylate group
of Bia.
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The H-bond pattern in the enzyme was similar to that of the free state, except
for Lys224, that was interacting with O13@Bia and O12@Bia, other Bia-CphA
interactions include O(14)@Bia-Nε@His196, and NH@Asn233-O(14)@Bia (Fig.
4.5), while O(12)@Bia interacts with Asn233 backbone amide in ES-1A, but not
in ES-2A; His196 is mobile in both adducts. The OH group of Bia was trapped be-
tween Thr119 and Thr157 sidechains, as in the X-ray structure of the adduct with
the Bia derivative.
CphA-Bia hydrophobic contacts involved Val67, that together with Tyr70 forms
the loop L1, and C(10) methyl@Bia and also with the C(17) and C(18) of the 3,5-
diaza-1-azoniobicyclo group.
Therefore, Bia was well anchored to the enzyme cavity and the distance be-
tween Wat2 and the C(7) (the carbon that undergoes the nucleophilic attack) of the
β -lactam ring is 3.3 ± 0.1 A˚ and 3.5 ± 0.1 A˚ for ES-1A and ES-2A. Consistently,
the RMSF of the Cα (Fig. 4.3) was similar to that of the free state, except for
L1 and L9, which were smaller, possibly because of the formation of interactions
involving Asn233, Val67 and Bia.
Thus, both MD structures could be considered as productive Michaelis com-
plexes.
In contrast, the MD simulations of ES-1B and ES-2B showed that Bia rear-
ranged dramatically or moved almost completely out of the active site. This may
be caused, at least in part, by the electrostatic repulsion between negatively charged
OH (Oz or OH-2) and carboxylate group of Bia. The latter pushed Bia outside the
active pocket and caused the breaking of the hydrogen bonds between Lys224 and
the O(12) of the carboxylic group of Bia, and the one between the His196 and the
other oxygen atom of the same group. As Bia moved outside of the active site, we
discarded both docking models in the B protonation state.
4.4 Discussion of results
The study of the structural and dynamic features of MβLs can provide useful infor-
mation for the design of new effective antibiotics or lactamase inhibitors, which are
likely to escape the selection of pathogens resistant to present agents. A key issue
in this respect is the knowledge of the protonation state of enzymatic active sites,
which is a prerequisite for investigating the reaction mechanism and for computer-
aided design of inhibitors. Here, we have addressed this issue in the context of
CphA, the only B2 MβLs for which the X-ray structure is presently available. The
stability in terms of structure and energetics of 11 plausible protomers of the active
site in the free state (Tab 4.1) was evaluated by QM and MD simulations. Two
protomers were the most likely ones. They were practically isoenergetic, repro-
duced the structural features of the active site in QM calculations and conserved
the protein fold during 10 ns of dynamics. The protomer A was characterized by
the presence of a Zn-coordinated water molecule and His118 protonated in Nε , and
the protomer B was characterized by an hydroxide Zn-coordinated and a diproto-
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Figure 4.5: (a) Main differences in docking pose of the antibiotic in ES-1A, ES-
2A, ES-1B and ES-2B. Red the orientation of Bia in models ES-1, in which the
carboxylic group binds directly to the Zn. Blue the orientation of the antibiotics for
models ES-2. The oxygen of the fourth metal ligand (either a water molecule (Waz)
in ES-2A or a hydroxide (Oz) in ES-2B), which binds the carboxylic group of Bia
in models 2, and those of the possibles nucleophiles (Wat2 in models ES-1A, ES-
2A and ES-2B, OH-2 for ES-1B) are also shown. (b) The substrate/enzyme stable
interactions, emerging from MD simulations, are shown: H-bonds and salt bridges
are represented by arrows, while the wavy lines indicate the hydrophobic contacts.
During the dynamics both ES-1A, ES-2A maintained all these interactions, while
ES-1B and ES-2B turned out to be unstable. Lys224 interacts with O(12) in model
ES-1A, while with O(13) in ES-2A.
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nated His118 (Fig. 4.1). Asp120 turns out to be deprotonated in both cases. Both
models contained a water molecule within ≈ 4 A˚ from the zinc and not bound
to this ion. The MD simulations of the protein in both protonation states further
confirmed that CphA possesses a compact fold, revealing, however, some degrees
of mobility of the L1 loop, helixα3/L5 and L9 regions, structures located at the
entrance of the active site.
In B1 enzymes, L3 loop is the analogous of L1 in B2, but it is longer, being formed
by 7-8 residues compared to only two residues, Tyr60 and Val67, in the latter sub-
class. NMR measurements [156] and classical MD calculations on B1 [157, 158],
showed that this loop, located at the entrance of the active site, is highly mobile,
and became stabilized by the binding of a substrate or an inhibitor.
In CphA, L1 edges the active site from the N-terminal domain, and a decrease
in mobility emerges from calculations, as a consequence of interaction with the car-
bapenem -SR groups upon substrate binding. These effects were not evidenced by
X-ray experiments and are unexpected findings of MD calculations, which suggest
a possible role of L1 for the mechanism of binding carbapenem molecules.
We conclude that an equilibrium between the two protonation states should be
considered for a detailed description of the structural properties of the enzymes in
resting state.
The binding of the substrate Bia was investigated by docking Bia in CphA’s
active site. Two different poses were considered. The first one was obtained start-
ing from the X-ray structure of the adduct of CphA with a Bia derivative [154], in
which the nucleophile (water molecule or an hydroxide) was located in a pocket
between His118 and Asp120 (models ES-1A and ES-1B). In particular, we have
used the experimental information, showing that in the structures of CphA in com-
plex with Bia derivative the substrate carboxylate group interacts directly with the
zinc and with Lys224. Docking was then performed assuming that this interaction
characterizes also the binding of the substrate before the nucleophilic attack.
The second pose was obtained by docking the Bia in the active site, in the struc-
tures obtained from CphA-A and CphA-B, preserving the main protein ligand in-
teractions as in previous pose, but assuming here that the carboxylic O13@Bia-Zn
bound is not present before the nucleophilic attack (models
ES-2A and ES-2B). This mode is built under the proposal that two solvent molecules
should be present in Zn environment to complete the catalytic reaction, as found in
all B1 MβLs [159, 24, 160, 161, 162, 163, 164, 165, 166, 157, 167, 168].
The dynamics of ES-1B and ES-2B caused either a dramatic rearrangement of
Bia or a departure of Bia from the active site, pointing to the instability of these
complexes. This instability may be caused, at least in part, by the electrostatic
repulsion between the Zn-bound hydroxide and Bia carboxylate.
In contrast, ES-1A and ES-2A turned out to be very stable during the dynamics.
Residues His196, Lys224 and Asn233 were crucial for Bia binding by means of
salt bridges or H-bonds with carboxylate and carbonyl groups.
Thus, our calculations suggest that Bia may bind in two ways to the protein,
and that the reaction mechanism of the CphA could be different from the one re-
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cently proposed by QM/MM calculations [97], in which the ligand binds directly
to the Zn.
In addition, our findings establish that the hydrolysis mechanism of members of
subclass B2 is different with respect to B1 MβLs, where a Zn(II) bound hydroxide
is believed to promote the cleavage of the β -lactam ring [25,27-33].
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Chapter 5
Insights from the reaction
mechanism of CphA enzyme
5.1 Summary
The bacterial metallo β -lactamases (MβLs) are rapidly evolving, because the evo-
lutionary pressure of β -lactam antibiotics. These enzymes accommodate one or
two zinc ions, in its ’Zn1’ and ’Zn2’ sites, responsible for substrate hydrolysis.
Recent X-ray studies on a member of the B2 MβLs, CphA from Aeromonas hy-
drophila, have prompted a variety of mechanistic studies of this important subclass,
specific for carbapenems.
Hybrid QM/MM simulations reported here, support a novel mechanistic view,
consistent with experimental data and pointing to a common functional role of the
zinc ion in the ’Zn2’ binding site in B1 and B2 MβLs. This single metal is able to
promote the activation of the nucleophile and the engagement of a catalytic water
for the completion of the hydrolytic cycle. Based on a variety of computational
studies along with recent experimental evidences, we conclude that the conserved
functional motif can be specifically targeted for the design of improved antibiotics
as well common inhibitors.
5.2 The Michaelis complexes
Based on classical molecular dynamics (MD) simulations described on 4, we sug-
gested that ES-1 [14, 169, 97] and ES-2 (Chart 5.1) are plausible Michaelis com-
plexes [169].
They differ essentially by one non-proteic ligand coordinated to the metal ion,
which is either the substrate (ES-1), as proposed specifically for this enzyme [14,
97], or a water molecule (ES-2), as already proposed across the B1 members [28,
27, 22, 23, 26].
The nucleophilic water would be activated, in both cases, by an H-bond accep-
tor, suggested to be either His118 [14] or Asp120 [97].
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Figure 5.1: Schematic representation of the postulated reaction mechanism of
CphA, a B2 MβL. Top panel: proposals reported so far [14]. In the Michaelis
complex ES-1, Wat1 would be activated by being deprotonated by a general base,
either His118 or Asp120. Subsequently, the negatively charged N(1) atom of the
substrate would be protonated. In path I an internal geometry rearrangement of
Int around the C(5)-C(6) bond, or the coming of a second water (Wat2) from the
bulk solvent (the two possibilities are depicted in blue and red respectively), could
bring a proton donor in a suitable position for its transfer to N(1)@Bia. In path II
such proton would come from the general base [97]: in the figure we show Asp120
as general base and proton donor. Bottom panel: possible catalytic mechanism
emerging from this work. In the Michaelis complex ES-2, two water molecules
are simultaneously present in the Zn catalytic pocket. As in ES-1, Wat1 would
be activated by a generalized base (His118 has been shown in this picture) and
performs the nucleophilic attack. However, the second water (Wat2), which is
bound to the Zn(II) ion and H-bonds to Bia carboxylate, could simultaneously act
as proton donor in the protonation of the negatively charged β -lactam nitrogen.
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Here, we used Car-Parrinello [170] DFT-BLYP [171, 172] based QM/MM
[173, 174] simulations to investigate the reaction mechanism of CphA with ES-1
and ES-2 conformations as initial reactant state. The free energy has been cal-
culated as function of a selected reaction coordinate, using the thermodynamics
integration method [152].
5.3 Reaction mechanism based on ES-1
The Michaelis complex. Substrate and Zn-protein interactions were maintained
during the QM/MM simulations. In particular, the substrate forms interactions with
Val67 and Lys224 (Fig. SI 3), consistently with mutagenesis studies [14, 175],
which point to an important role of these two residues.
However, substrate binding to the Zn(II) ion, which is a key facet of this mech-
anism [14, 97] was readily disrupted (see O(2)@Bia-Zn distance Tab. SI 1). This
might be a consequence of the salt bridge formed between the substrate and Lys224
(Fig. SI 3). As a result, Wat1 could enter the coordination shell of Zn(II), produc-
ing a slightly distorted tetrahedral geometry of the metal environment (Tab. SI
2).
Key factors for the alterations of Zn(II) polyhedron, as seen during QM/MM
simulations, may include temperature effects and/or by the electrostatic and me-
chanical contribution of the enzyme frame. In fact the simple energy minimization
of the QM part only (i.e. in the gas phase), using exactly the same exchange-
correlation functional (BLYP [171, 172]) and plane wave basis set, turned out to
give similar results to those reported by Xu et al. [97], which energy-minimized a
similar model using B3LYP [171, 172, 176] and 6-31++G** basis set: in particu-
lar, Bia’s carboxylate remained bound to the metal ion. These results explain why
in the previous report this Michaelis complex appeared to be stable, whereas it is
actually unstable. Thus, several effects, including the mobility of the Lys224, the
presence of the protein frame and the accurate description of the chemical bonding
between Zn and donor atoms (as obtained in a QM framework), are needed for a
proper modeling of the Michaelis complex.
5.3.1 Simulation of the enzymatic reaction.
The distance between the nucleophilic water oxygen O@Wat1 and the C(7) β -
lactam carbon (dO−C(7)) was selected as reaction coordinate (RC, see also Methods
section). This choice is similar to those used in others studies [22, 23, 97] and, to
a first approximation, is the natural one to describe the direct nucleophilic attack.
dO−C(7) was progressively decreased in steps of 0.2 A˚ until the transition state
(TS1) was identified at 1.7 A˚ (namely, where the force on the constraint changed
sign). The coordination polyhedron of ES-1 was maintained until TS1 was reached;
then the polyhedron was subsequently modified due to the simultaneous occurrence
of several events (Fig. 5.2): (i) Bia’s carboxylate oxygen and the β -lactam nitro-
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gen N(1) entered in the ligand shell of Zn; (ii) Asp120 and Wat1 detached from
the metal ion; (iii) the catalytic Wat1 was deprotonated by Asp120, becoming an
activated hydroxide; (iv) the β -lactam C-N bond weakened, as shown by the in-
creased distance and fluctuation of the C-N bond (the distance increased from 1.5
± 0.05 A˚ to 1.7 ± 0.1 A˚).
Figure 5.2: Investigation of ES-1. Top: representative structures of the adduct
(called E+S in the picture), intermediate (Int) and products (E+P) along the re-
action path starting from ES-1. QM atoms along with the key residue Lys224
are shown in bold and thin licorice respectively. Middle: evolution of some key
distances as function of RC, during the nucleophilic attack. In particular: d1 =
d(H@Wat1, d2 = d(N(1)@Bia, d3 = d(N(1)@Bia-C(7)@Bia), d4 = d(O(2)@Bia-
Zn). Bottom: evolution of key distances during the protonation nucleophilic at-
tack, at various RC values (d1 = d(N(1)@Bia-Zn), d2 = d(O(2)@Bia-Zn) and d3 =
d(N(1)@Bia-Zn)).
The calculated activation free energy for this step is ∆F‡ ∼ 15 ± 3 kcal/mol,
and this value is not dissimilar from the experimentally measured data (∆G‡14
kcal/mol) [14] and the computational estimation by Xu et al. (∆F‡ ∼ 14 ±) [97].
By further decreasing RC, we identified a stable intermediate of the reaction
(Int), and calculated that ∆F(Int) ∼ 9 ± 2 kcal/mol. From TS1 to Int, the C-N dis-
tance further increased (Tab. SI 1) until the bond was cleaved. In the intermediate
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the substrate directly coordinated with the metal ion: N(1)@Bia and O(2)@Bia
formed a direct coordination bond with Zn(II) (Tab. SI 1). The remaining lig-
ands were Cys221 and His263, and the coordination sphere was characterized by a
highly distorted tetrahedral geometry (see Fig. 5.2, structure of Int, and Tab. SI 1).
For the rest of the active site, the same H-bond network of ES-1 was maintained,
apart from the interactions formed by atoms involved in the nucleophilic attack.
N(1)@Bia and O(2)@Bia were located in a similar position as that occupied
by the same atoms in the crystal structure of the complex Bia derivative/CphA [14].
From the Int state, two different scenarios have been proposed for the second step
of the reaction speculated: (i) a rotation of C(5)-C(6) bonds along with the entry
of a water molecule (Wat2) in the catalytic pocket (path I, Fig. 5.1) [14], or (ii) a
proton transfer from Asp120@H to N(1)@Bia (path II, Fig. 5.1) [97].
We explored both these proposals by molecular simulation methods starting
from the Int structure.
As for (i), we noticed that the large internal structural rearrangement of Int,
and/or possible re-solvation of the active site, required time-scales well beyond
first principle QM/MM calculations. Therefore some hints may be obtained by
classical MD In the time-scale investigated (5 ns) our calculations showed no rel-
evant rearrangements or re-solvation within the active site pocket. Although these
events may occur in longer time-scales, our calculations provided no support for
the mechanism of Garau et al. [14].
As for (ii), we performed constrained QM/MM, in which the distance between
H@Asp120 and N(1)@Bia, selected as our reaction coordinate for this step, was
progressively decreased (Fig. 5.2 and Tab. SI 2). The resulting free energy barrier
is ∆F(Int)‡ ∼ 15 ± 2 kcal, giving a barrier of ∼ 24 ± 3 kcal/mol for the overall
reaction. This value highly overestimates the experimental finding, even more if
one considers the well-known deficiencies of DFT-BLYP scheme in calculating the
energy of transition states and intermediates [177, 178]. Thus, our calculations do
not seem to support the hypothesis proposed in ref. [97].
We conclude that the Michaelis complex ES-1 may not be the correct one to
describe the complete hydrolysis in CphA. Furthermore, the two-steps mechanism
proposed by Xu et al. [97] is ruled out due to the high free energy barrier of the
reaction. The mechanism which undergoes internal rearrangements, as proposed
by Garau et al. [14], is not supported (but not ruled out) by the present calculations.
5.4 Reaction mechanism based on ES-2
The Michaelis complex. In contrast to ES-1, during the QM/MM simulations,
the Zn(II) coordination polyhedron was fully maintained and conserved a regular
tetrahedral geometry (Tab. SI 3). Remarkably, the ligand-Zn distances agree with
the characteristic values obtained for a variety of Zn proteins [179]. In particular,
Wat2 remained within a distance of 2.1 A˚ from the Zn ion, keeping also its H-bond
to Bia’s carboxylate. The ligand/protein interactions were also maintained (Tab. SI
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3) and were similar to ES-1, except that His196 H-bonded not only to O(1)@Bia
but, at times also to O(2)@Bia. Thus, the existence of Val67 and Lys224-substrate
interactions are consistent, also in this case, with molecular biology data [175],
which show the role of these two residues for the function of the enzyme.
Importantly, the β -lactam was kept in an suitable orientation for the nucle-
ophilic attack by a H-bond between O(2)@Bia and Wat2.
5.4.1 Simulation of the enzymatic reaction.
The mechanism was investigated using as reaction coordinate the distance between
O@Wat1 and C(7)@Bia (starting value dO@−C(7)=3.1 A˚). All the bonds which
characterized the Michaelis complex were maintained during the simulations per-
formed at different values of RC, before reaching the TS. A change of the constraint
force sign was observed, at dO−C(7)=1.7 A˚, as in ES-1, leading to TS formation.
Conversely to the reaction starting from ES-1, the complete cleavage of the β -
lactam moiety occurred in a single step, characterized by the following events in
the sub-ps timescale (see Fig. 5.3): (i) deprotonation of the nucleophile by His118,
which became di-protonated (this event was simultaneous to the nucleophilic at-
tack); (ii) protonation of the nitrogen N(1) by Wat2, which became transiently a
metal-bound hydroxide group, (iii) proton transfer from Wat1 to the metal bound
hydroxide, restoring the water molecule Wat2 (Fig. 5.3); replacement of Wat2 in
Wat1’s position in ES-2; (iv) finally, a proton transfer from His118 in its charged
state to the transient form of Bia. This led to the product of the enzymatic reaction
(Fig. 5.3).
The calculated activation free energy for the entire concerted process was ∆F(Int)‡ ∼
15 ± 3 kcal/mol, in good agreement with experimental findings [14].
The agreement with the experimental data allows us to discuss the available
information on the functional role of key residues in the active site [175], in light
of this novel mechanism. His118 has been shown to be an important residue for the
reaction, as the kcat of H118A decreases by three orders of magnitude relative to
wild-type (wt) [175]. Consistently in our mechanism His118 acts as general base
and it is therefore crucial for the function.
His196 is also believed to be a key residue, because it may create an oxyan-
ion hole [14]. Somehow consistently with this hypothesis, our averaged D-RESP
charges of O(1)@Bia, in both Michaelis complexes and the transition state (−0.53±
0.04) are more negative than in simulation of the substrate in water (−0.36±
0.04). The negative potential is created by a specific H-bond between His196 and
O(1)@Bia.
A role of His196 has been more recently established by the decrease of kcat by
two order of magnitudes in the H196A mutant [175]. However, we have to point
out that our calculations were not able to distinguish the effect of the residue on
the transition state relative to the Michaelis complex, possibly because of the well
known approximations in the calculations of the atomic charges.
The role of these two His residues for the catalysis has been recently further
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Figure 5.3: Investigation of ES-2. Here we show the time evolution of ES-2 at
dO−C(7)=1.7 A˚ (TS2): in the top part of the figure, the movement of QM atoms
(in bold licorice) along with Lys224 (thin licorice) is shown (snapshots were taken
from the QM/MM constrained run at value of dO−C(7)=1.7 A˚). In the bottom part,
key distances vs time evolution at TS2 are plotted.
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confirmed by another experimental study: a B1 enzyme (the so-called BCII from
Bacillus cereus [180]) has been engineered so as to be similar to a mononuclear
MβL, in which only one metal ion binds to the ’Zn2’ site (’Zn2’ MβLs), as found
in the B2 subclass (Fig. SI 1). This was achieved by two mutations, H118S and
H196S, and in the presence of only one equivalent of Zn2+. The resulting impaired
catalytic activities of these mutants suggests that residues His118 and His196, from
the ’Zn1’ site, play a key role for catalysis in ’Zn2’ MβLs.
Two residues playing an important role for the affinity of the substrate have
been identified by molecular biology data. The first is Lys224: in the K224Q
mutant, the KM measured for the carbapenem, was 10 times greater than in the
wild type enzyme [175]. A structural basis for a role of the residue for binding is
obviously provided by our model of the Michaelis complex. Indeed Lys224 forms
a strong salt bridge with the protein (Fig. SI 3), as found for the B1 subclass ([181].
In addition, Val67 form hydrophobic interactions with the methyl group at position
4 of the substrate. At the speculative level, we may suggest that in the case of Ile,
these might be affected, whilst with Asp they will be reduced.
We conclude that our mechanism provides a molecular basis for the role of all
the residues which have shown to affect kcat or KM.
Part III
Directed evolution studies of B1
MβL BcII
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Chapter 6
Directed evolution studies of B1
MβL BcII
6.1 Summary
Protein evolution is crucial for organismal adaptation and fitness. This process
takes place by shaping a given three dimensional fold for its particular biochemi-
cal function within the metabolic requirements and constraints of the environment.
The complex interplay between sequence, structure, functionality and stability that
gives rise to a particular phenotype has hampered the identification of traits ac-
quired through evolution. This is further complicated by the fact that mutations are
pleiotropic, and interactions between mutations are not always understood. Antibi-
otic resistance mediated by β -lactamases represents an evolutionary paradigm in
which organismal fitness depends on the catalytic efficiency of a single enzyme.
Here we have dissected the structural and mechanistic features acquired by
an optimized metallo-β -lactamase obtained by directed evolution. We have solved
the crystal structure of the evolved lactamase, and performed a kinetic, biophysical,
mechanistic and in vivo study of this enzyme and related mutants, which allowed us
to trace a general picture of molecular evolution of metallo-β -lactamases directly
linked to organismal fitness, measured in terms of bacterial survival. We show that
antibiotic resistance mediated by this enzyme is driven by two mutations with sign
epistasis, which correlates to an in vitro synergistic effect of these mutations on
the enzyme activity. One mutation stabilizes a catalytically relevant intermediate
by fine tuning the position of one metal ion in the active site, while the other acts
by augmenting the enzyme’s flexibility. We found that enzyme evolution (and the
associated antibiotic resistance) occurred at the expense of protein stability, reveal-
ing that metallo-β -lactamase have not exhausted their robustness threshold. Our
results demonstrate that flexibility is an essential trait that can be acquired dur-
ing evolution on stable protein scaffolds. The fact that metallo-β -lactamases can
evolve by optimizing the reaction mechanism suggests that these enzymes possess
a large evolutionary potential, in contrast with serine-β -lactamases. These results
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suggest that these metalloenzymes have been recruited more recently by bacte-
ria to supplement the catalytic profile of serine-β -lactamases. Directed evolution
aided by a thorough characterization of the selected proteins can be successfully
employed to predict future evolutionary events and to design inhibitors with an
evolutionary perspective.
6.2 Introduction
Protein evolution is crucial for organismal adaptation and fitness. This process
takes place by shaping a given three dimensional fold for its particular biochemi-
cal function within the metabolic requirements and constraints of the environment.
The evolution of a protein relies on a subtle interplay between sequence, struc-
ture, functionality and stability, that is manifested in a particular phenotype. many
studies rely on statistical description of adaptive molecular changes, but recent ef-
forts have aimed at identifying changes in sequence and structure that affect fitness
within a defined protein fold. The identification of such structural traits acquired
through evolution allows both the reconstruction of ancestral genes and the pre-
diction of future evolutionary events. The latter perspective could be immensely
valuable for anticipating the molecular features that enhance bacterial resistance
to antibiotics, and therefore designing strategies against this clinical threat. The
main mechanism of bacterial resistance to β -lactam antibiotics is the expression
of β -lactamases, a family of enzymes whose evolution is continuously challenged
by the indiscriminate clinical use of antibiotics. MβLs and serine β -lactamases
(sβLs) are not evolutionary related, their mechanisms of action are entirely dif-
ferent, and MβLs display a broader substrate spectrum, with catalytic efficiencies
that are in general far from being diffusion limited. Since MβLs may have not yet
achieved optimal fitness, the investigation of their future evolutionary potential is
both appealing and extremely important clinically.
Directed evolution on the Bacillus cereus MβL, BcII, by DNA shuffling and
selection by cephalexin (Fig. 1.10) resistance (a poor substrate of BcII) elicited
an evolved variant, M5, displaying an enhanced cephalexinase activity. Surpris-
ingly, this enhancement did not take place at the expense of impaired hydrolytic
activity toward other substrate, thus generating an enzyme with broader substrate
spectrum. The evolved enzyme M5 contains four mutations (N70S, V112A, L205S
and G262S), all of them located outside the active site. We solved the X-ray struc-
ture of M5 (Table 6.1), which shows that none of these mutations entails changes
in the global fold (0.4 A˚ RMSD on all non-hydrogen atoms vs WT BcII).
The active site of BcII can be described as a shallow groove flanked by loops
L3 and L10, hosting two Zn(II) ions located at its floor (Fig. 6.1).
Zn1 is bound to 3 His residues (His116, His118 and His196), while Zn2 is
coordinates to Asp120, Cys221 and His263. Despite all mutations are remote, Zn2
has moved closer to Zn1 by 0.7-1.0 A˚ in the mutant 6.2, while preserving the same
ligand set. In the evolved variant M5, the two closest mutations to the active site are
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G262S N70S N70S/G262S M5 BcII WT
Substrates kcat KM kcat /KM kcat KM kcat /KM kcat KM kcat /KM kcat KM kcat /KM kcat KM kcat /KM
Benzylpenicillin 320 150 2.13 x 106 543 ¿3200 1.69 x 105 636 172 3.69 x 106 570 574 9.93 x 105 1020 662 1.54x106
Imipenem 40.1 227 1.76 x 105 ND ¿3000 1 x 105 93.2 63.1 1.47 x 106 129 721 1.79 x 105 279 687 4.06 x105
Nitrocefin 680 50.2 1.36 x 107 1.73 14.5 1.19 x 106 460 30.2 1.52 x 107 81.3 27.8 2.92 x 106 30.1 9.82 3.07 x106
Cefotaxime 87.3 60.2 1.45 x 106 115 113 1.01 x 106 182 32.6 5.58 x 106 44.9 30.3 1.49 x 106 80.5 43.3 1.86 x106
Cephalexin 70.4 217 3.24 x 105 2.05 331 6.19 x 103 221 146 1.51 x 106 41.2 209 1.97 x 105 3.32 125 2.65 x104
Table 6.1: Kinetic parameters for the hydrolysis of different β -lactam substrate
by BcII wild type and BcII mutants: M5, G262S, N70S and N70S/G262S. units
kcat (sec −1), KM (µM) and kcat /KM (sec−1 M−1).
Figure 6.1: BcII secondary structure, and close up of the active site and of the loops
which surrounded it.
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N70S and G262S, both located below the active site floor. The hydroxyl oxygen
of Ser262 is 3.1 A˚ from the Cys221 sulfur, and 3.48 A˚ from the Cys221 backbone
nitrogen atom, resembling two interactions present in the plasmidic MβL IMP-1,
in which a Ser residue is naturally found in this position.
Figure 6.2: Comparison of the active sites of BcII WT (gray) and M5 mutant
(green). The Zn2 ion (green) of the M5 mutant is more exposed that the WT one.
Ser262 thus behaves as a second shell ligand of ”Zn2” and at the same time
connects L10 and L12. Ser70 is located in a β -strand two residues upstream from
Pro68, which defines the N-terminus of a conserved mobile loop (L3). The absence
of the Asn70 sidechain results in the removal of two H-bonds with Pro261 and
Gly264, which flank the ”Zn2” ligand His263 and the mutated residue 262 (located
in loop L12). These are the only H-bonds connecting loops L3 and L12. Another
notable change in the interloop connections is that Arg121 (from loop L7) adopts a
different conformation in M5, resulting in the loss of a H-bond of its guanidinium
group with the backbone oxygen of residue 262 (loop L12).
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1
In order to examine the influence of each of these mutations in the active site
structure, mutants N70S, G262S and N70S/G262S were obtained, and the metal
site was probed by substitution of the native Zn(II) ion by Co(II). The electronic
spectra of the Co(II) derivatives (Fig. 6.3) show that the ligand field bands between
450 and 660 nm corresponding to the ”Zn1” site are identical in all variants,
revealing that this metal site is unaltered by either of these mutations. However,
a Cys221-Co(II) charge transfer band at 343 nm (a reported of the ”Zn2” site) is
perturbed only when Ser262 is present, pointing to the key role of the S262-C221
H-bond.
Figure 6.3: Electronic spectra of Co(II)-substituted BcII, M5, G262S, N70S and
N70S/G262S in 10 mM Hepes (pH 7.5) 0.2 M NaCl. The enzyme concentrations
were 250, 220, 180, 120 and 250 µM respectively.
These experiments reveal that (1) G262S is the only mutation that has direct
effect on the metal site structure (via the latter H-bond), and (2) the Zn2 site is
perturbed, while the ”Zn1” site does now show any change upon this mutation.
The catalytic performances of the single mutants N70S and G262S and the dou-
ble mutant N70S/G262S were assayed with five different β -lactam substrates (Fig.
6.4).
The G262S mutation selectively enhances the catalytic efficiency toward ni-
1Most of the work on this research project was carried out experimentally. Therefore, it is reported
in this thesis (in italics).
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Figure 6.4: Relative enzyme activities of the G262S, N70S and N70S/G262S
mutants compared to BcII WT against benzylpenicillin (PEN), nitrocefin (NTR),
imipenem (IMI), cefotaxime (CTX) and cephalexin (CLX). Relative activity is the
ratio of the mutant’s kcat /KM value to that of WT. Y axis is in log scale.
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trocefin and cephalexin (the substrate used in the directed evolution experiment),
while the catalytic efficiency of the single mutant N70S is compromised for all sub-
strates tested. However, the catalytic efficiency of the double mutant was enhanced
for all substrates, with a notable 56-fold increase in activity towards cephalexin.
This observation reveals a synergistic effect between these two mutations, suggest-
ing that these two site are coupled. G262S, the only mutation that has a direct
impact on the structure of the metal site, induces the greatest activity enhancement
on cephalexin hydrolysis, driven by a 20-fold increase on kcat (Tab. 6.1). This
suggests that evolution may have acted by stabilizing the enzyme-transition state
complex. This hypothesis was tested by studying the hydrolysis of nitrocefin, a
chromophoric cephalosporin that is a useful probe of the catalytic mechanism of
MβLs. Whereas nitrocefin hydrolysis by wt BcII under single turnover conditions
proceeds through a direct conversion of substrate to product, the same reaction
catalyzed by G262S BcII reveals the accumulation of an intermediate, as indicated
by the rise of an absorption band with a maximum at 665 nm that decays within 10
msec (Fig. 6.5).
Figure 6.5: Relative enzyme activities of the G262S, N70S and N70S/G262S
mutants compared to BcII WT against benzylpenicillin (PEN), nitrocefin (NTR),
imipenem (IMI), cefotaxime (CTX) and cephalexin (CLX). Relative activity is the
ratio of the mutant’s kcat /KM value to that of WT. Y axis is in log scale.
This spectral feature is identical to that reported for nitrocefin hydrolysis by
the MβL CcrA from B. fragilis, and attributed to an anionic intermediate in which
a negatively charged nitrogen is bound to the metal ion at the ”Zn2” site. In terms
of steady-state parameters, the G262S mutation has increased kcat from 30 to 680
s−1, that is even larger than the one displayed by CcrA (250 s−1). This confirms
that the directed evolution has led to stabilization of a catalytically relevant inter-
mediate, thus acting on the rate-limiting step of the reaction. The G262S mutation,
resulting from a single base mutation, has already been observed in enzymes coded
by transferable genetic elements in opportunistic and pathogenic bacteria: IMP-1
and its putative ancestor, IMP-6, differ only by this mutation, which expands the
enzyme’s substrate spectrum. This relatively recent event in the natural evolution
in MβLs may have also acted by accelerating the rate-limiting step of the reac-
tion, confirming the hypothesis that MβLs may not yet have reached their optimal
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performance. Recent mutagenesis studies on BcII have shown that shifting the po-
sition of the ”Zn2” site into a more buried location (and thereby also increasing
the ”Zn1”-”Zn2” distance) results in a severe impairment of the lactamase activ-
ity. ”Zn2” is much more exposed in M5 than in WT BcII (Fig. 6.2), and its active
site display the shortest metal-metal distance among all native and mutant enzymes
from this family (3.16-3.39 A˚). Thus, MβL-mediated resistance can still evolve fur-
ther by improving the rate-limiting step through changes in the active site, and
specifically the location of ”Zn2”. The data discussed above provide a structural
explanation for the effect of the G262S mutation on catalysis, but do not account
for the selection of the N70S mutation, nor explain the broader substrate spectrum
displayed by the double N70S/G262S mutant. The N70S mutation is deleterious
for the activity of WT BcII, but beneficial when acting on G262S BcII (Fig. 6.4),
suggesting that it acts as a compensatory mutation. The crystal structure of M5
shows that the principal effect of removing the Asn70 side chain is the elimination
of the two H-bonds connecting loops L3 and L12 (Fig. 6.1).
The spectroscopic data reveal that N70S does not alter the metal site struc-
ture, and therefore support the idea that this mutation acts exclusively on the loop
structure and dynamics. Thus, the restoring effect of the N70S mutation is to act by
enhancing loop flexibility. Compensatory mutations in evolution frequently act to
restore protein stability. Guanidine hydrochloride-induced protein unfolding was
therefore analyzed for the different enzymes. BcII is an extremely stable protein
(∆Gµ = 18.4 kcal/mol, see Fig. 6.6), and the G262S substitution has a large impact
on its stability, reducing it by 13.9 kcal/mol. The N70S mutation causes a reduction
of 5.6 kcal/mol, and the double mutant N70S/G262S is even less stable than either
of the single mutants (∆Gµ = 3.3 kcal/mol). It is clear that although N70S serves
to restore a broad substrate profile and enhance activity for all substrate tested, it
does not compensate for the loss of protein stability.
In SβLs, mutations that enhance enzyme activity and destabilize the protein
are compensated by stabilizing mutations (e.g. M182T in TEM-1). Thus, the fitness
landscape of these enzymes is determined by a trade-off between the activity and
stability features introduced by the mutations. MβLs present a different picture:
the compensatory mutation (N70S) does not stabilize, in fact it further destabilize,
the protein and instead facilitates greater flexibility in the loops flanking the sub-
strate binding cavity. The exceptionally high stability of the MβL fold compared
with SβLs (∆Gµ for the TEM-1 is 10 kcal/mol) is such that there may be no need
yet to compensate the destabilizing effects brought upon the introduced mutations.
This suggests that robustness does not play a central role in the fitness landscape
of MβL evolution. Instead, the impact of the restoring mutation on loop flexibility
suggests that a coupled network of motions would be operative in MβLs-mediated
catalysis, that could be of importance for the evolution of these enzymes given
their broad substrate spectrum. Recently, Park and coworkers succeeded in elic-
iting MβL activity in the scaffold of glyoxalase II. This variant is still 4000-fold
less active that a native MβL. At the light of the present results, loop engineering
aimed to increase the flexibility may be exploited to further enhance the lactamase
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Figure 6.6: Equilibrium denaturation curves of wild type BcII, m5, G262, N70S
and N70S/G262S in 50 mM Hepes (pH 7.5) 0.2 M NaCl at different GdnCl concen-
trations monitored by fluorescence spectroscopy. The theoretical curves are drawn
by usgin a three state model (WT and N70S) and two-state model (M5, G262S and
N70S-G262S).
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activity in that case. Protein stability is not necessarily associated with evolu-
tionary fitness: indeed, optimum protein stability may fall within a narrow range
with highly stable protein lacking the required flexibility to meet their functional
needs. The MβL studied here, BcII, is a remarkably stable protein with scope for
enhancing its activity at the expense of thermodynamic stability. Thus, in this case,
fitness takes place at the expenses of loosing thermodynamic stability, with a clear
epistatic effect caused by the N70S mutation by augmenting the flexibility of the
active site loops. MβLs thus follow a different evolutionary paradigm compared to
SβLs, and clearly represent an alarming clinical threat.
MβLs are a relatively recent response to antibiotic usage, and there is limited
information on mutations that increase resistance. Nevertheless, one of the muta-
tions generated in this study has already been found in nature (G262S in IMP-1),
demonstrating that studies such as this are capable of predicting the future course
of bacterial evolution of resistance. In the present case, the effect of this mutation
on the rate-limiting step of the reaction allows us to propose a strategy for de-
signing a mechanism-based inhibitors with an evolutionary perspective. Anionic
transition state analogues targeted to bind the ”Zn2” site are expected to be good
inhibitors, instead of ligands aimed to fit into an oxyanion hole (a common strategy
for designing hydrolase inhibitors, that has failed for MβLs).
6.4 Discussion and conclusions
G262S mutant simulation results 2 A were fully consistent with experimental ev-
idence of the S262-C221 H-bond in the mutants; in addition , they pointed to a
larger flexibility of loop L3 in the mutants relative to WT (Fig. 6.7). Loop L10
instead, is less flexible in G262S BcII that in WT, and it shows the largest mobil-
ity in the double mutant. The double mutant’s active site is wider than the other
two. The simulations of WT and mutant Michaelis complexes showed that both
loop are overall less flexible that the corresponding free states. They close over
the substrate, getting close to each other. Such conformational change involves the
formation of an electrostatic interaction (weaker in WT relative to the mutants) be-
tween the carboxylate moiety of the substrate and the conserved lys224. loop L10
and l3 are more flexible in the double mutants than in the other two 6.7). These
simulations together with the structural, functional and mechanistic data previously
discussed, allow us to postulate the folowing scenario for MβL evolution. The
G262S mutation is responsible for the enhanced cephalexinase activity through a
two-fold effect: the H-bond between Ser262 and Cys221 not only allows loop L10
to adopt a less open conformation upon cephalexin binding, but it also leads to a
better positioning of the ”Zn2” ion. ”Zn2” has been suggested to play an essential
role in substrate binding and orientation (in concert with Lys224), and in favoring
C-N bond cleavage through the stabilization of a negative charge on the β -lactam
nitrogen. While enhancing cephalexin hydrolysis, this relative tightening of L10
2Detailed results of the MD simulations performed on this subject are reportred in Appendix A
6.4 Discussion and conclusions 89
with respect to L12, does not favor penicillin, cefotaxime and imipenem hydrolysis
(Fig. 6.1).
Figure 6.7: Root Mean Square fuctuation of the Cα from MD simulations of the
free enzymes and adducts.
Instead, the N70S mutation eliminates two H-bonds connecting L3 and L12,
giving rise to a larger active site groove and thus compensating for the effect of
G262S and rendering an enzyme with a broader substrate spectrum (and even fur-
ther enhanced activity towards cephalexin).
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Chapter 7
Conclusions
MβLs counteract the beneficial action of β -lactam antibiotics against bacterial in-
fections by enzymatically hydrolyzing their β -lactam rings.
In this thesis I have addressed important issues regarding the mechanism of
resistance, by computational methods.
Most efforts have been devoted to dissecting analogies and differences among
the reaction mechanisms in two different subclasses of these enzymes. This infor-
mation may be of relevance to design ligands able to inhibit more than one MβL.
I have focused on one subclass, the B2 MβL, and compared my results with those
obtained for the B1 subclass, for which some mechanistic insights had already
been obtained in our lab. My calculations were based on the CphA B2 MβL from
Aeromonas hydrophila, for which an X-ray structure has been solved [14].
A key issue and prerequisite to investigate the reaction is the exact knowledge
of the active site residues protonation state [83].
We have used a two-steps strategy to address this issue: first we have evaluated
structural determinants and energetics of active site models by DFT calculations,
and then we have constructed the Michaelis complex.
The stability of eleven protomers was analyzed considering their energetics and
RMSD values relative to the X-ray. Our calculations suggested that two protomers
(A and B Fig. 7.1) may be present for the unbound enzyme, which could be reason-
ably assumed to be in equilibrium. Protomer A was characterized by the presence
of a Zn-coordinated water molecule. One of the second shell ligands, His118, was
protonated in Nε . Protomer B was characterized by a hydroxide bound to Zn.
His118 was diprotonated.
Docking procedures along with MD simulations were performed to provide a
structural model of the Michaelis complex with Biapenem substrate. Two binding
modes were obtained (ES-1 and ES-2). The nucleophile molecule was located in
a pocket between His118 and Asp120. The carboxylate group of the antibiotic
interacts directly with the zinc in one binding mode, and with a metal-bound water
in the other one. The Michaelis complex featured only protonation state (A). Thus,
the presence of the substrate affected the protonation states of the enzyme. Of
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these, ES-1 is that proposed experimentally based on the X-ray structure [14] (see
Fig. 7.2).
Hybrid QM/MM simulations, based on the two binding modes, reported in this
work, support a novel mechanistic view, different from the one proposed by Garau
and partially addressed in the other computational work on CphA [97]. Based
on our calculations, we suggest that the reaction proceeds through a previously
unrecognized single-step concerted mechanism. In our proposed pathway a water
molecule performs the nucleophilic attack to the β -lactam carbonyl and a second
Zn-bound water protonates the β -lactam nitrogen. The reaction was characterized
by a free energy barrier of about 15 kcal/mol, in agreement with experimental data
[14]. Our mechanism provides a structural role for all of the residues which have
been shown to be important for the function of B2 MβLs. These include i) His118,
which orients the catalytic water and acts as generalized base; ii) His196 which
creates an oxyanion hole, as proposed by Garau et al. [14]; iii) Val67 and Lys224,
which affect substrate binding. Furthermore the calculations point to the key roles
of the metal ion in the ”Zn2” site and of two water molecules for the hydrolysis, in
agreements with recent experimental [182, 183, 184] and theoretical [23] findings.
We now come to our comparison with hydrolysis mechanism of the others
subclasses. We suggest that the ”Zn2” site, conserved in both B1 and B2 MβLs,
is able to indirectly contribute to substrate binding by a water molecule which H-
bonds the antibiotic’s carboxylate group (Fig. 7.3). Moreover, the metal in the
”Zn2” site is able to activate a water molecule as a proton donor for the completion
of the antibiotics hydrolysis. In addition, both B1 and B2 MβLs are suggested to
proceeds through a single step mechaism. At a speculative level, we suggest that
some aspects of this mechanism might be shared also by the B3 MβL members
Figure 7.1: Active site protomers of CphA emerging from our DFT-BLYP calcu-
lations. The 4th Zn ligand is a water molecule (Waz) in A, and an OH group (Oz)
in B.
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Figure 7.2: ES-1A (a) and ES-2A (b) MD average structures. The putative water
molecules (Wat2) acting as nucleophile in the enzymatic reaction are highlighted
with circles; the second zinc coordinated water (Waz) is indicated with dashed
circle in (b).
[10], for the high similarity in the Zn content in the active site, along with the
composition of Zn ligands. We hope that our results may help to design of novel
inhibitors capable to counteract the action of more than one MβLs subclass.
In the second part of the thesis, I have focused on the exploration of possible
pathway of evolution of a B1 MβL, the BcII from Bacillus cereus. Directed evo-
lution on these bacteria yielded optimized variants able to confer more resistance
than native enzyme. These variants harbor four mutations remote from the active
site that contribute to broaden its substrate repertoire.
Our MD calculations on these mutants showed that G262S modifies the Zn.
This of course may affect the geometry of the second shell ligands. QM/MM
calculations could better address this issue. N70S-G262S cause an increase of
size and flexibility of the active sive cavity. This provides a rationale for the larger
spectrum of substrate hydrolized by the enzyme. It is also our hope that new ligand
inhibitors for B1 BcII, may take into account the structural role of these mutants
[185].
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Figure 7.3: Comparison between the reaction mechanism proposed for B1 (on the
top panel) and that proposed for B2 MβL (on the bottom part), in which the key
role of the ’Zn2’ binding site in both subclasses emerges clearly. The metal loaded
in this site is involved, almost simultaneously, either in nucleophilic attack of the
β -lactam ring and in the protonation of the β -lactam nitrogen.
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Appendix A
Details of MD simulation of WT,
G262, N70S-G262S BcII mutants.
A.1 Methods and general comments
The structure of di-Zn(II) BcII from Bacillus cereus (PDB entry code 1BC2, ) was
selected as the reference starting structure for all our calculations. Loop L3, which
is not present in the corresponding coordinates file, was reconstructed and modeled
as already reported . The starting structures for G262S BcII and N70S-G262S BcII
were obtained by superimposing the backbone atoms of the serine residues over
those of the corresponding wild type residues. The resulting χ1 and χ2 angles
were verified to fall in the most favorable regions. Each system was immersed in a
box (85.6 A˚ x 80.3 A˚ x 85.9 A˚) of water molecules (approximately 17,000), with
4 chloride anions for neutralizing the excess charge. The force field parameters for
the protein frame, the counterions and for water are those of the AMBER PARM98
citeAMBER7 and TIP3P , respectively. For the coordination sphere of the Zn(II)
ions, we followed the same scheme as for CphA. For the antibiotics, the gaff force
field was used , as for the charges. Electrostatic interactions were computed us-
ing the Particle Mesh Ewald (PME) algorithm . A cutoff of 12 A˚ was used for
van der Waals and for short range component of electrostatic interactions. Bonds
involving hydrogen atoms were constrained using the SHAKE algorithm . An in-
tegration time step of 1.5 fs was used. Loop L3 and the sidechains of mutations
were first energy minimized using a steepest descent algorithm. The systems were
initially relaxed with 5,000 steps of optimization of the solvent, while the protein
was held fixed, followed by 5000 steps of optimization of the whole system. The
systems were slowly heated to 300 K performing runs at constant volume and con-
stant temperature using Langevin Dynamics . Constant temperature and pressure (1
atm, 300 K) MD runs were finally performed . The pressure coupling was accom-
plished with Langevin piston and the temperature with the Nose´-Hoover method
. 10 ns of trajectory were produced for every systems, with the aim of NAMD
programs .Subsequently, Cephalexin (Cfa) was docked inside the last MD snap-
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Figure A.1: Close up of the Asn70 environment: all its Hbond are outlined
shots of the three structures. The three Michaelis complexes underwent the same
computational protocol as the free states.
It turned out that the geometries of active site residues in all the simulations,
were stable and well conserved (Tab. A.1 and A.2), as well as the fold.
A.2 Free enzymes
A.2.1 Wild type BcII
N70 kept the two H-bonds (NH2 group of sidechain) with CO@P261 (davO−H = 1.92
± 0.17 A˚, ΘD−H−A 162± 8 deg), and CO@G264 (davO−H = 1.82± 0.08 A˚, ΘD−H−A
163 ± 8 deg), during all the simulation, while H-bond with Thr56 was lost and it
was replaced by another between OH@Th56 with CO@Ser69 (davO−H = 2.12 ± 0.3
A˚, ΘD−H−A 153 ± 10 deg) (Fig. A.1).
A.2.2 G262S
The starting structure of the OH@S262 (Fig. A.3), was characterized by the H-
bond with Oδ2@D120 (H...O distance of ≈ 2 A˚, angle between acceptor-H-donor
≈ 156 degree).
This contact broke at 4.9 ns, and was replaced by the OH@S262-S@C221
interaction, that remained until end of this simulation (7.5 ns) (dH−S 2.3 ± 0.1 A˚,
angles ΘOH−S 143.9o ± 8.6).
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Figure A.2: Comparison between initial (red) and final (blue) Cα trace in WT
simulation.
Figure A.3: Starting structure of BC2 G262S, with the contact OH@S262
Oδ2@D120
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Figure A.4: Starting structure (only backbone trace, in blue) and final (red) one.
Loop L12 is located near the base of loop L3 (6.1). The two loops interacted
through an H-bond between O@Pro68 and NδH@His263, and this interaction was
maintained until 6 ns, when it was broken in favor of formation of a new interaction
with NH@Gly264.
Asn70, in the WT BcII was connected to Loop L12 with two interloop H-
bonds of the NH2 group, one with Pro202 and a second with Gly205. Moreover,
the CO group of Asn70 was involved in a intragroup interaction with Thr56, a
residue located in β3-strand, placed in close proximity of loop L3. The interaction
between Pro202 and Thr56 was lost, while the one with Gly205 was maintained:
Asn70 mediated interaction between the two loops, L3 and L12.
All these events led to a movement of L3 (roto-translation) which put it toward
L10 (Fig. A.5).
A.2.3 N70S-G262S
The starting structure, showed in Fig. A.6, was characterized by the presence of
interaction between L3-L12, achieved through H-bond between OH@Ser70 and
Pro261 (Fig. A.6)
The contact between OH@S262 and S@C221 was present for about 80% of
the total simulated time (average dS−OH 2.19 A˚ ±0.19 A˚, average angle ΘOH−S
154deg ± 2deg), and in the remaining time it was replaced by a second H-bond,
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Figure A.5: Initial and final structure (only backbone is showed) of G262S: as
could be seen only the three loops L3, L10 and to a less degree L12, were signifi-
cantly different.
Figure A.6: Starting structure of G262S G70S: the OH group of serine Hbonds
with CO backbone of Pro261.
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Figure A.7: Intra-structure interaction between Ser70 and Thr56, both located at
the base of loop L3
namely between OH@C221 with Oδ2@D120.
Asn70-Pro261 interaction was observed only in the first half of the total sim-
ulation, and was lost in the second half, while another interaction between Ser70
and Thr56 (Fig. A.7) was formed: a crucial interaction connecting L3/L12 was
lost, while a second new interaction intrastructure was formed.
This compensate the conformational changes induced by the G262, and on the
contrary resulted in an increased degree of mobility of loop L3, which in fact is the
opposite effects of what observed in the case of G262S single mutant).
A.3 Simulation of Cfa complexes
A.3.1 WT
In order to evaluate the stability of the antibiotics in the catalytic pocket of the
enzyme, the distance between the N1@Cfa from Zn2 was used. The distance was
stale during all the MD simulation (dN1−Zn2 3.4 ± 0.1 A˚).
Eventual changes in the orientation of the plane of β -lactam ring in the catalytic
pocket were evaluated monitoring the angle Θ between Zn2-N1@Cfa-C6@Cfa
(ΘZn2−N1−C6 111 ± 6 deg) and another one defined ad Θ Zn2-N1@Cfa-C8@Cfa
(ΘZn2−N1−C8 91 ± 6 deg), and both turned out to be stable during the simulated
time.
The rotation of the β -lactam plane respect the line Zn1-Zn2 was followed
ddmeasuring the dihedral evolution angle defined by the atoms Zn1-Zn2-N1@Cfa-
C6@Cfa (χ = -94 ± 5).
Zn2-O2@Cfa was stable (daver=1.95 A˚ ± 0.08A˚), the salt bridge NH@Ala119
and CO@Cfa present for 91 % of the simulation (daverH−O=1.99 A˚ ± 0.15 A˚,
ΘDA=157.3 ± 11.7): the breaking of this bond was connected to the decrease of
χ mentioned before (the plane of β -lactam rotates for a moment respect to Zn1-
Zn2 line). Hydrophobic interactions with C2@Cfa and Methyl@Cfa (R1 substitute
group): at first Methyl@Cfa interacts only with the backbone of Val67, and Phe62
was far from C2@Cfa.
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Figure A.8: Close up of the ending structure of simulation. Hydrophobic interac-
tion were outlined in the circle.
There were little differences in the hydrophobic interaction pattern from N70S-
G262S mutant, mainly contacts involved with Val67 (Fig. A.8).
Different tridimensional position of the loop L3, could be connected to the
Hbond between Nδ1H@H263 and CO@Val67 (this helped to keep Val67 close
to Cfa) (present 76 % of time, and when present daverH−O=2.08 A˚ ± 0.18 A˚,
ΘDA=150.2 ± 10.5).
A.3.2 G262S
Also in this simulation it turned out that the Cfa was well trapped in the active
site, and any significant fluctuation in the four parameter chosen above were ob-
served during all the dynamic (dN1−Zn2 = 3.52 ± 0.15, ΘZn2−N1−C6 = 111 ± 6 deg,
ΘZn2−N1−C8 = 90 ± 6 deg, χ = -93 ± 5)
Zn2-O2@Cfa was stable (daver=1.94 A˚ ± 0.08A˚), as well as the salt bridge
between NH3@Lys224-O3@Cfa (daverN−O=2.85 A˚ ± 0.15 A˚).
H-bond between NH@Ala119 C8@Cfa was always present during the simula-
tion (daverH−O=2.07 A˚ ± 0.22 A˚, ΘDA=154.2 ± 12.5).
Hydrophobic interactions of Methyl@Cfa (R1 substitute) and of C2@Cfa: they
were quite similar of those of N70s-G262S mutant, but here Phe62 lost its hy-
drophobic contact with Cfa at the end of simulation ( Fig. A.9 and Fig.A.10).
Other key interprotein interactions were:
S@C68-OH@Ser262 contact, present always in this simulation, while Asn70
interact with the Thr56 and Pro261 (Hbond present 100% : daverH−O=2.02 ± 0.28,
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Figure A.9: Docking pattern compared between three simulations: in blue the
structure of single mutant, in red the one of the N70S-G262S mutant and in yellow
those of WT (only sidechains of protein residues), the different position of residues
involved in the hydrophobic packing could be seen.
Figure A.10: Distance between one of the C of the phenyl ring of Phe62, and
C8@Cfa. the distance decreased with time, and at the end Phe was not involved in
hydrophobic packing of the Cfa.
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Figure A.11: The three distances of loops, compared in the three simulation of
Cfa adducts: as could be seen in that case the effect is the opposite of what seen
in free enzymes simulations, where the maximum opening of loops L3 and L10
was observed for Double mutant (as a consequence of its increased mobility due
to mutation in position 70). In that case the increased mobility allow the loops (in
particular L3) to fit better and docking in a more efficent way the Cfa.
ΘDA=152.57 ± 13.3 for the one with Pro, and daverH−O=2.05 ± 0.28, ΘDA=161.64
± 11.2 for the one with Thr).
In that simulation O@Pro68 H-bonds always with NδH@H263 (daverH−O=1.90
± 0.16, ΘDA=151.72 ± 12.6).
All these effects are connected, and caused a different orientation of loop L3 (
see Fig. A.11).
A.3.3 N70S-G262S
dN1−Zn2 was stale during all the MD simulation (dN1−Zn2 = 3.5 ± 0.15 A˚), as well
as the other selected parameter (ΘZn2−N1−C6 111± 6 deg, ΘZn2−N1−C8 88± 6 deg,
χ = -91 ± 5)
Other interactions were the following:
i) Zn2-O2@Cfa (dav = 1.94 ± 0.01 A˚),
ii) the salt bridge between NH3@Lys224...O3@Cfa (davN−O = 2.8 ± 0.2),
iii) H-bonds between NH@Ala119 and C8@Cfa (daverH−O=2.1± 0.3, ΘDA=148
± 14).
iv) Hydrophobic interaction of Methyl@Cfa (R1 substitute in Cfa) with Gly232
(average distance between C2@Cfa and Cα@Gly232 4.16 A˚ ± 0.45) and Val67
(average distance between C@Cfa and Cβ@Val=4.69 ±0.045 ). Another interac-
tion was the one between phenyl group @Phe62 and C2@Cfa (av. dist. 4.05 ±
110 Details of MD simulation of WT, G262, N70S-G262S BcII mutants.
Figure A.12: Initial (blue) and final (red) backbone trace.
0.67) and with Trp87. All interactions formed at the beginning of simulation, and
were stable during the dynamic.
The HO@Ser262-S@Ser221 contact, present from the beginning of the sim-
ulation, was lost in the last 2 ns, in favor of a H-bond with Oδ2@Asp84, while
Ser70 didn’t form any stable interaction, but many at different times, with the three
residues, and also with Ser69 and with its own C=O backbone atom.
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force field Bc2 WT Bc2 G262S BC2 G262S N70S
ZN1 ZN2 .3.85 3.22 ± 0.02 3.18 ± 0.02 3.15 ± 0.02
ND@H88-Z1-NE@H49 101.22 95.5 ± 1.8 97.31 ± 2.8 84.9 ± 1
NE@H86-Z1-ND@H88 101.22 98.12 ± 1.8 101.09 ± 1.6 97.02 ± 0.8
NE@H86-Z1-NE@H49 107.95 96.22 ± 3.7 94.60 ± 1.1 96.22 ± 0.7
O2@D90-Z2-S@C68 107.23 102.408 ± 1.0 100.0 ± 1.8 * 103.3 ± 0.8
O2@D90-Z2-NE@H21 73.96 67.88 ± 0.4 68.78 ± 0.6 68.65 ± 0.74
S@C68Z2-NE@H21 107.23 114.5 ± 0.8 117.19 ± 0.7 117.21 ± 2.1
Table A.1: Structural parameter for the active sites, simulation of free enzyme
force field Bc2 WT-Cfa Bc2 G262S-Cfa BC2 G262S N70S-Cfa
ZN1 ZN2 .3.85 3.14 ± 0.09 3.15 ± 0.10 3.22 ± 0.10
ND@H88-Z1-NE@H49 101.22 88.14 ± 4.8 88.93 ± 5.3 97.82 ± 5.5
NE@H86-Z1-ND@H88 101.22 97.3 ± 4.3 95.84 ± 4.3 98.52 ± 5.0
NE@H86-Z1-NE@H49 107.95 96.63 ± 4.3 97.18 ± 4.5 97.03 ± 4.4
O2@D90-Z2-S@C68 107.23 103.93 ± 3.1 104.24 ± 3.2 * 105.54 ± 3.4
O2@D90-Z2-NE@H21 73.96 67.18 ± 2.7 68.00 ± 2.8 67.06 ± 3.6
S@C68Z2-NE@H21 107.23 103.93 ± 3.1 104.24 ± 3.2 114.7 ± 3.3
Table A.2: Structural parameter for the active sites, simulation of adducts
112 Details of MD simulation of WT, G262, N70S-G262S BcII mutants.
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